Electroluminescent metal complexes with benzotriazoles

ABSTRACT

This invention relates to electroluminescent metal complexes with benzotriazoles of the formula (I), a process for their preparation, electronic devices comprising the metal complexes and their use in electronic devices, especially organic light emitting diodes (OLEDs), as oxygen sensitive indicators, as phosphorescent indicators in bioassays, and as catalysts.

This invention relates to electroluminescent metal complexes with benzotriazoles, a process for their preparation, electronic devices comprising the metal complexes and their use in electronic devices, especially organic light emitting diodes (OLEDs), as oxygen sensitive indicators, as phosphorescent indicators in bioassays, and as catalysts.

Organic electronic devices that emit light, such as light-emitting diodes that make up displays, are present in many different kinds of electronic equipment. In all such devices, an organic active layer is sandwiched between two electrical contact layers. At least one of the electrical contact layers is light-transmitting so that light can pass through the electrical contact layer. The organic active layer emits light through the light-transmitting electrical contact layer upon application of electricity across the electrical contact layers.

It is well known to use organic electroluminescent compounds as the active component in light-emitting diodes. Simple organic molecules such as anthracene, thiadiazole derivatives, and coumarin derivatives are known to show electroluminescence. Semiconductive conjugated polymers have also been used as electroluminescent components, as has been disclosed in, for example, in U.S. Pat. No. 5,247,190, U.S. Pat. No. 5,408,109 and EP-A-443 861. Complexes of 8-hydroxyquinolate with trivalent metal ions, particularly aluminum, have been extensively used as electroluminescent components, as has been disclosed in, for example, U.S. Pat. No. 5,552,678.

Burrows and Thompson have reported that fac-tris(2-phenylpyridine) iridium can be used as the active component in organic light-emitting devices. (Appl. Phys. Lett. 1999, 75, 4.) The performance is maximized when the iridium compound is present in a host conductive material. Thompson has further reported devices in which the active layer is poly(N-vinyl carbazole) doped with fac-tris[2-(4′,5′-difluorophenyl)pyridine-C′²,N]iridium(III). (Polymer Preprints 2000, 41(1), 770.)

J. A. C. Allison et al., J. Heterocyclic Chem. 12 (1975) 1275-1277 discloses 2-phenyl-1,2,3-triazole chloro complexes of palladium and their use as catalysts in the synthesis of chlorinated phenyl triazines.

M. Nonoyama and C. Hayata, Transition Met. Chem. 3 (1978) 366-369 describe cyclometallations of 2-aryl-4,5-dimethyl-1,2,3-triazoles [H(C—N)] with palladium(II), platinum(II), rhodium(III) and iridium(III)chloride which results in [MCl(C—N)]₂ for M=Pd, or Pt and [MCl(C—N)₂]₂ species for M=Rh, or Ir. These complexes react with monodentate ligands, L, such as pyridine and tri-n-butylphosphine to give MCl(C—N)L and MCl(C—N)₂L complexes

US20020055014 relates to a light-emitting device comprising a phosphorescent compound. Preferred phosphorescent compounds include compounds having a partial structure represented by the formula shown below

wherein M represents a transition metal; Q_(k1) represents an atomic group necessary for forming a 5- or 6-membered aromatic ring; and Q_(k2) represents an atomic group necessary for forming a 5- or 6-membered aromatic azole ring. The 5- or 6-membered aromatic azole ring completed by Q_(k2) may include triazole.

US20010019782 discloses a light-emitting material comprising a compound having a partial structure represented by the following formula

wherein Z¹¹ and Z¹² each represent a nonmetallic atom group required to form a 5- or 6-membered ring with at least one of carbon atom and nitrogen atom, said ring optionally having a substituent or forming a condensed ring with the other ring; Ln¹ represents a divalent group; Y¹ represents a nitrogen atom or carbon atom; and b² represents a single bond or double bond. Among the preferred examples of the 5- or 6-membered ring formed by Z¹¹ and Z¹² are 1,2,3-triazole rings, and 1,2,4-triazole rings. The divalent group Ln¹ does not comprise a single bond.

Phosphorescent bis-cyclometalated iridium complexes containing benzoimidazole-based ligands are described by W.-S. Huang et al. in Chem. Mater. 16 (2004) 2480-2488.

WO06/000544 relates to electroluminescent metal complexes with triazoles and benzotriazoles, a process for their preparation, electronic devices comprising the metal complexes and their use in electronic devices, especially organic light emitting diodes (OLEDs), as oxygen sensitive indicators, as phosphorescent indicators in bioassays, and as catalysts.

JP2005023070, JP2005023071, JP2005023072, JP2005029782, JP2005029783, JP2005029784 and US2006/0287498 disclose metal coordination compounds comprising benzotriazole based ligands. The metal coordination compounds are distinguished from the compounds of formula I according to the present invention by the group bonded to the nitrogen atom of the benzotriazole backbone, which is not derived from 1-naphthyl.

However, there is a continuing need for electroluminescent compounds, especially orange, or red emitters, having improved efficiency.

Accordingly the present invention is directed to compounds (metal complexes) of the formula

R¹ to R¹⁰ are independently of each other hydrogen, an organic substituent, or fluorine, or two substituents R¹ to R¹⁰ which are adjacent to each other, together form a ring,

L is a mono-, or bi-dentate ligand,

n is an integer 1 to 3,

m is 0, an integer 1 to 4 depending on the ligand and the metal, and

M is a metal with an atomic weight of greater than 40, especially Fe, Ru, Ni, Co, Ir, Pt, Pd, Rh, Re, or Os, very especially Ir, or Pt, a process for their preparation, electronic devices comprising the metal complexes and their use in electronic devices, especially organic light emitting diodes (OLEDs), as oxygen sensitive indicators, as phosphorescent indicators in bioassays, and as catalysts.

The compounds of the present invention are preferably orange, or red emitters having a λ_(max) above about 520 nm, especially above about 560 nm and very especially above about 600 nm. The 2H-benzotriazole compound or compounds should have a NTSC coordinate of between about (0.62, 0.37) and about (0.68, 0.32), especially a NTSC coordinate of between about (0.64, 0.35) and about (0.68, 0.32), very especially a NTSC coordinate of about (0.67, 0.33) or (0.68, 0.32).

According to the present invention the metal complex comprise at least a 2H-benzotriazole ligand, i.e. it may comprise two or three or more 2H-benzotriazole ligands.

The term “ligand” is intended to mean a molecule, ion, or atom that is attached to the coordination sphere of a metallic ion. The term “complex”, when used as a noun, is intended to mean a compound having at least one metallic ion and at least one ligand. The term “group” is intended to mean a part of a compound, such a substituent in an organic compound or a ligand in a complex. The term “facial” is intended to mean one isomer of a complex, Ma₃b₃, having octahedral geometry, in which the three “a” groups are all adjacent, i.e. at the corners of one triangular face of the octahedron. The term “meridional” is intended to mean one isomer of a complex, Ma₃b₃, having octahedral geometry, in which the three “a” groups occupy three positions such that two are trans to each other, i.e. the three “a” groups sit in three coplanar positions, forming an arc across the coordination sphere that can be thought of as a meridion. The phrase “adjacent to” when used to refer to layers in a device, does not necessarily mean that one layer is immediately next to another layer. The term “photoactive” refers to any material that exhibits electroluminescence and/or photosensitivity.

The metal complexes of the present invention are characterized in that at least one ligand is derived from a benzotriazole compound. Suitable benzotriazoles are known or can be produced according to known procedures. The synthesis of suitable benzotriazoles is, for example, described in WO03/105538, and WO05/054212 as well as the references cited therein.

The metal is generally a metal M with an atomic weight of greater than 40, Preferably the metal M is selected from the group consisting of Fe, Ru, Ni, Co, Ir, Pt, Pd, Rh, Re, Os, Tl, Pb, Bi, In, Sn, Sb, Te, Ag and Au. More preferably the metal M is selected from Ir, Rh and Re as well as Pt and Pd, wherein Ir is most preferred.

R¹, R², R³ and R⁴ are independently of each other hydrogen, CN, fluorine, C₁-C₂₄alkyl, C₁-C₂₄alkoxy, C₁-C₂₄alkylthio, C₁-C₂₄ perfluoroalkyl, C₆-C₁₈aryl, which is optionally substituted by G; —NR²⁵R²⁶, —CONR²⁵R²⁶, —COOR²⁷, or —COR²⁸; or C₂-C₁₀heteroaryl, which is optionally substituted by G; or

R¹ and R², R² and R³, R³ and R⁴, R⁵ and R⁶, R⁷ and R⁸, R⁸ and R⁹, R⁹ and R¹⁰ are a group of formula

or R⁶ and R⁷ are a group of formula

wherein A⁴¹, A⁴², A⁴³, A⁴⁴, A⁴⁵, and A⁴⁶ are independently of each other H, halogen, CN, C₁-C₂₄alkyl, C₁-C₂₄ perfluoroalkyl, C₁-C₂₄alkoxy, C₁-C₂₄alkylthio, C₆-C₁₈aryl, which may optionally be substituted by G, —NR²⁵R²⁶, —CONR²⁵R²⁶, or —COOR²⁷, or C₂-C₁₀heteroaryl; especially

wherein

R²⁵ and R²⁶ are independently of each other C₆-C₁₈aryl, C₆-C₁₈aryl which is substituted by C₁-C₁₈alkyl or C₁-C₁₈alkoxy; C₁-C₂₄alkoxy which is interrupted by —O—, or —NR^(25′)—, C₇-C₁₈aralkyl, or C₁-C₂₄alkyl, R²⁷ and R²⁸ are independently of each other C₁-C₂₄alkyl, C₆-C₁₈aryl, or C₇-C₁₈aralkyl, which may optionally be substituted by C₁-C₁₈alkyl or C₁-C₁₈alkoxy;

R⁵ is hydrogen, fluorine, C₁-C₂₄alkyl, CN, C₁-C₂₄alkyl, which is substituted by F, C₆-C₁₈-aryl, C₆-C₁₈-aryl which is substituted by C₁-C₁₂alkyl, C₁-C₁₈alkoxy, or C₂-C₁₈heteroaryl,

R⁶ is hydrogen, CN, halogen, especially F, C₁-C₂₄alkyl, which may be substituted by F, C₁-C₂₄alkoxy; C₁-C₂₄alkoxy which is interrupted by —O—, or —NR²⁵—, C₆-C₁₈aryl, C₆-C₁₈aryl which is substituted by C₁-C₁₂alkyl, C₂-C₁₈heteroaryl, or C₁-C₈alkoxy, —NR²⁵R²⁶, —CONR²⁵R²⁶, —COOR²⁷, or

wherein

E² is —S—, —O—, or —NR^(25′)—, wherein R^(25′) is C₁-C₂₄alkyl, or C₆-C₁₀aryl, or

R⁵ and R⁶ are a group of formula

wherein A⁴¹, A⁴², A⁴³, A⁴⁴,

A⁴⁵, and A⁴⁶ are as defined above,

A^(11′), A^(12′), A^(13′), and A^(14′) are independently of each other H, halogen, CN, C₁-C₂₄alkyl, C₁-C₂₄alkoxy, C₁-C₂₄alkylthio, —NR²⁵R²⁶, —CONR²⁵R²⁶, or —COOR²⁷,

R⁷, R⁸, R⁹, and R¹⁰ are independently of each other H, halogen, especially F, CN, C₁-C₂₄alkyl, C₂-C₁₈-hereroaryl, or C₆-C₁₀aryl, which may be substituted by C₁-C₁₈alkyl, or C₁-C₁₈alkoxy, C₁-C₂₄alkoxy, C₁-C₂₄alkoxy which is interrupted by —O—, or —NR²⁵—, C₁-C₂₄alkylthio, —NR²⁵R²⁶, —CONR²⁵R²⁶, or —COOR²⁷, wherein R²⁵, R²⁶ and R²⁷ are as defined above and G is C₁-C₁₈alkyl, —OR³⁰⁵, —SR³⁰⁵, —NR³⁰⁵R³⁰⁶, —CONR³⁰⁵R³⁰⁶, or —CN, wherein R³⁰⁵ and R³⁰⁶ are independently of each other C₆-C₁₈aryl; C₆-C₁₈aryl which is substituted by C₁-C₁₈alkyl, or C₁-C₁₈alkoxy; C₁-C₁₈alkyl, or C₁-C₁₈alkyl which is interrupted by —O—; or

R³⁰⁵ and R³⁰⁶ together form a five or six membered ring, in particular

R⁵ is preferably hydrogen, or C₁-C₂₄alkyl, C₆-C₁₈aryl, C₆-C₁₈aryl which is substituted by C₁-C₁₈alkyl, or C₁-C₁₈alkoxy; or fluorine; most preferably hydrogen, C₆-C₁₈aryl, or C₆-C₁₈aryl which is substituted by C₁-C₆alkyl, or C₁-C₆alkoxy. Among hydrogen, C₆-C₁₈aryl, and C₆-C₁₈aryl hydrogen is most preferred.

R⁶ is preferably hydrogen, C₁-C₂₄alkyl, such as methyl, ethyl, or n-butyl, C₁-C₁₈alkoxy, such as methoxy, ethoxy, n-propoxy, iso-propoxy, n-butoxy, 2-butoxy, iso-butoxy, or 2-ethylhexyloxy, C₆-C₁₈-aryl, C₆-C₁₈-aryl which is substituted by C₁-C₁₈alkyl, or C₁-C₁₈alkoxy, —NR²⁵R²⁶, or fluorine; most preferable hydrogen, C₆-C₁₈aryl, C₆-C₁₈aryl which is substituted by C₁-C₆alkyl, or C₁-C₆alkoxy, or —NR²⁵R²⁶, wherein R²⁵ and R²⁶ are independently of each other C₁-C₁₈alkyl, or C₆-C₁₈aryl which may be substituted by C₁-C₆alkyl, or C₁-C₆alkoxy, such as —NR²⁵R²⁶, wherein R²⁵ and R²⁶ are methyl, R²⁵ and R²⁶ are phenyl, or R²⁵ is phenyl and R²⁶ naphthyl.

R⁷, R⁸, R⁹, and R¹⁰ are preferably hydrogen, C₁-C₂₄alkyl, C₆-C₁₈aryl, C₆-C₁₈aryl which is substituted by C₁-C₁₈alkyl, or C₁-C₁₈alkoxy, —NR²⁵R²⁶, or fluorine; most preferably hydrogen, C₆-C₁₈-aryl, C₆-C₁₈-aryl which is substituted by C₁-C₆alkyl, or C₁-C₆alkoxy, or R⁵ and R⁶ are a group of formula

Compounds of formula I are preferred, wherein

R² and R³ are H, CF₃, CN, or fluorine,

R⁶ is H, C₁-C₂₄alkyl, such as methyl, ethyl, or n-butyl, C₁-C₁₈alkoxy, such as methoxy, ethoxy, n-propoxy, iso-propoxy, n-butoxy, 2-butoxy, iso-butoxy, or 2-ethylhexyloxy, NR²⁵R²⁶, wherein R²⁵ and R²⁶ are C₁-C₁₈alkyl, or C₆-C₁₈aryl, such as phenyl, or naphthyl which may be substituted by C₁-C₈alkyl, or C₁-C₈alkoxy.

M is Pd, Rh, or Re, especially Pt, or Ir,

L is a bidentate ligand,

m is 0, or 1, and n is 1, or 2, if M is Pd, or Pt,

m is 0, 1, or 2, and n is 1, 2, or 3, if M is Rh, Ir or Re, and

R¹, R⁴, R⁵, R⁷, R⁸, R⁹ and R¹⁰ are hydrogen.

Monodentate ligands are preferably monoanionic. Such ligands can have O or S as coordinating atoms, with coordinating groups such as alkoxide, carboxylate, thiocarboxylate, dithiocarboxylate, sulfonate, thiolate, carbamate, dithiocarbamate, thiocarbazone anions, sulfonamide anions, and the like. In some cases, ligands such as β-enolates can act as monodentate ligands. The monodentate ligand can also be a coordinating anion such as halide, nitrate, sulfate, hexahaloantimonate, and the like. Examples of suitable monodentate ligands are shown below:

The monodentate ligands are generally available commercially.

Among the compounds of formula I compounds having a structure (Va), (Vb), (Vc); (VIa), (VIb), (VIc); (VIIa), (VIIb); (VIIIa), or (VIIIb) below are more preferred:

wherein

M² is Rh, or Re, especially Ir,

R² and R³ are independently of each other H, C₁-C₈alkyl, C₁-C₈ perfluoroalkyl, especially CF₃, or CN,

R⁶ is H, —NR²⁵R²⁶, or C₁-C₁₈alkoxy, wherein R²⁵ and R²⁶ are independently of each other C₁-C₁₈alkyl, or C₆-C₁₀aryl, especially phenyl, which may be substituted by one, or more groups C₁-C₁₈alkoxy, or C₁-C₁₈alkyl,

L is a bidentate ligand, and

L′″ is a monodentate ligand, and

M⁴ is Pd, especially Pt.

Most preferred are compounds of formula Va and Vb which show orange or red luminescence. Of particular interest are compounds of formula Va, wherein

M² is Ir,

R² and R³ are H, or one of R² and R³ is C₁-C₈alkyl, or C₁-C₈ perfluoroalkyl, especially CF₃, and the other is H,

R⁶ is H, or C₁-C₁₈alkoxy, and

L is

In a preferred embodiment of the present invention the ligand is a (monoanionic) bidentate ligand. In general these ligands have N, O, P, or S as coordinating atoms and form 5- or 6-membered rings when coordinated to the iridium. Suitable coordinating groups include amino, imino, amido, alkoxide, carboxylate, phosphino, thiolate, and the like. Examples of suitable parent compounds for these ligands include β-dicarbonyls (β-enolate ligands), and their N and S analogs; amino carboxylic acids(aminocarboxylate ligands); pyridine carboxylic acids (iminocarboxylate ligands); salicylic acid derivatives (salicylate ligands); hydroxyquinolines (hydroxyquinolinate ligands) and their S analogs; and diarylphosphinoalkanols (diarylphosphinoalkoxide ligands).

Examples of such bidentate ligands L are

wherein

R¹¹ and R¹⁵ are independently of each other hydrogen, C₁-C₈alkyl, C₆-C₁₈aryl, C₂-C₁₀heteroaryl, or C₁-C₈perfluoroalkyl,

R¹² and R¹⁶ are independently of each other hydrogen, C₆-C₁₈aryl, or C₁-C₈alkyl, and

R¹³ and R¹⁷ are independently of each other hydrogen, C₁-C₈alkyl, C₆-C₁₈aryl, C₂-C₁₀heteroaryl, C₁-C₈ perfluoroalkyl, or C₁-C₈alkoxy, and

R¹⁴ is C₁-C₈alkyl, C₆-C₁₀aryl, or C₇-C₁₁aralkyl,

R¹⁸ is C₆-C₁₀aryl,

R¹⁹ is C₁-C₈alkyl, C₁-C₈ perfluoroalkyl,

R²⁰ is C₁-C₈alkyl, or C₆-C₁₀aryl,

R²¹ is hydrogen, C₁-C₈alkyl, or C₁-C₈alkoxy, which may be partially or fully fluorinated,

R²² and R²³ are independently of each other C_(q)(H+F)_(2q+1), or C₆(H+F)₅, R²⁴ can be the same or different at each occurrence and is selected from H, or C_(q)(H+F)_(2q+1),

q is an integer of 1 to 24, p is 2, or 3, and

R⁴⁶ is C₁-C₈alkyl, C₆-C₁₈aryl, or C₆-C₁₈aryl, which is substituted by C₁-C₈alkyl.

Examples of suitable phosphino alkoxide ligands

(WO03040256) are listed below:

-   3-(diphenylphosphino)-1-oxypropane [dppO] -   1,1-bis(trifluoromethyl)-2-(diphenylphosphino)-ethoxide [tfmdpeO].

Examples of particularly suitable compounds HL,

from which the ligands L are derived, include

The hydroxyquinoline parent compounds, HL, can be substituted with groups such as alkyl or alkoxy groups which may be partially or fully fluorinated. In general, these compounds are commercially available. Examples of suitable hydroxyquinolinate ligands, L, include:

-   8-hydroxyquinolinate [8hq] -   2-methyl-8-hydroxyquinolinate [Me-8hq] -   10-hydroxybenzoquinolinate [10-hbq]

In a further embodiment of the present invention the bidentate ligand L is a ligand of formula

wherein the ring A,

represents an optionally substituted aryl group which can optionally contain heteroatoms, the ring B,

represents an optionally substituted nitrogen containing aryl group, which can optionally contain further heteroatoms, or the ring A may be taken with the ring B binding to the ring A to form a ring.

The preferred ring A includes a phenyl group, a substituted phenyl group, a naphthyl group, a substituted naphthyl group, a furyl group, a substituted furyl group, a benzofuryl group, a substituted benzofuryl group, a thienyl group, a substituted thienyl group, a benzothienyl group, a substituted benzothienyl group, and the like. The substitutent on the substituted phenyl group, substituted naphthyl group, substituted furyl group, substituted benzofuryl group, substituted thienyl group, and substituted benzothienyl group include C₁-C₂₄alkyl groups, C₂-C₂₄alkenyl groups, C₂-C₂₄alkynyl groups, aryl groups, heteroaryl groups, C₁-C₂₄alkoxy groups, C₁-C₂₄alkylthio groups, a cyano group, C₂-C₂₄acyl groups, C₁-C₂₄alkyloxycarbonyl groups, a nitro group, halogen atoms, alkylenedioxy groups, and the like.

In said embodiment the bidentate ligand

is preferably a group of formula

wherein R²⁰⁶, R²⁰⁷, R²⁰⁸, and R²⁰⁹ are independently of each other hydrogen, C₁-C₂₄alkyl, C₂-C₂₄alkenyl, C₂-C₂₄alkynyl, aryl, heteroaryl, C₁-C₂₄alkoxy, C₁-C₂₄alkylthio, cyano, acyl, alkyloxycarbonyl, a nitro group, or a halogen atom; the ring A represents an optionally substituted aryl or heteroaryl group; or the ring A may be taken with the pyridyl group binding to the ring A to form a ring; the alkyl group, alkenyl group, alkynyl group, aryl group, heteroaryl group, alkoxy group, alkylthio group, acyl group, and alkyloxycarbonyl group represented by R²⁰⁶, R²⁰⁷, R²⁰⁸, and R²⁰⁹ may be substituted; or

R²⁰⁸ and R²⁰⁹ or R²⁰⁷ and R²⁰⁸ are a group of formula

wherein A⁴¹, A⁴², A⁴³, A⁴⁴, A⁴⁵ and A⁴⁶ are as defined above.

Examples of preferred classes of such bidentate ligands L are compounds of the formula

wherein Y is S, O, NR²⁰⁰, wherein R²⁰⁰ is C₁-C₄alkyl, C₂-C₄alkenyl, optionally substituted C₆-C₁₀aryl, especially phenyl, —(CH₂)_(r)—Ar, wherein Ar is an optionally substituted C₆-C₁₀aryl, especially

a group —(CH₂)_(r′)X²⁰, wherein r′ is an integer of 1 to 5, X²⁰ is halogen, especially F, or Cl; hydroxy, cyano, —O—C₁-C₄alkyl, di(C₁-C₄alkyl)amino, amino, or cyano; a group —(CH₂)_(r)OC(O)(CH₂)_(r″)CH₃, wherein r is 1, or 2, and r″ is 0, or 1;

—NH-Ph, —C(O)CH₃, —CH₂—O—(CH₂)₂—Si(CH₃)₃, or

Another preferred class of ligands L is described in WO06/000544, of which the following can advantageously be used according to the present invention:

wherein

Q¹ and Q² are independently of each other hydrogen, C₁-C₂₄alkyl, or C₆-C₁₈aryl, A^(21′) is hydrogen,

A^(22′) is hydrogen, or C₆-C₁₀aryl,

A^(23′) is hydrogen, or C₆-C₁₀aryl,

A^(24′) is hydrogen, or

A^(23′) and A^(24′), or A^(23′) and A^(24′) together form a group

wherein R^(205′), R^(206′), R^(207′) and

R^(208′) are independently of each other H, or C₁-C₈alkyl,

R^(42′) is H, F, C₁-C₄alkyl, C₁-C₈alkoxy, or C₁-C₄ perfluoroalkyl,

R^(43′) is H, F, C₁-C₄alkyl, C₁-C₈alkoxy, C₁-C₄ perfluoroalkyl, or C₆-C₁₀aryl,

R^(44′) is H, F, C₁-C₄alkyl, C₁-C₈alkoxy, or C₁-C₄ perfluoroalkyl, and

R^(45′) is H, F, C₁-C₄alkyl, C₁-C₈alkoxy, or C₁-C₄ perfluoroalkyl.

Another preferred class of bidentate ligands L is a compound of formula

wherein R²¹⁴ is hydrogen, halogen, especially F, or Cl; C₁-C₄alkyl, C₁-C₄perfluoroalkyl, C₁-C₄alkoxy, or optionally substituted C₆-C₁₀aryl, especially phenyl,

R²¹⁵ is hydrogen, halogen, especially F, or Cl; C₁-C₄alkyl, C₁-C₄ perfluoroalkyl, optionally substituted C₆-C₁₀aryl, especially phenyl, or optionally substituted C₆-C₁₀perfluoroaryl, especially C₆F₅,

R²¹⁶ is hydrogen, C₁-C₄alkyl, C₁-C₄ perfluoroalkyl, optionally substituted C₆-C₁₀aryl, especially phenyl, or optionally substituted C₆-C₁₀perfluoroaryl, especially C₆F₅,

R²¹⁷ is hydrogen, halogen, especially F, or Cl; nitro, cyano, C₁-C₄alkyl, C₁-C₄ perfluoroalkyl, C₁-C₄alkoxy, or optionally substituted C₆-C₁₀aryl, especially phenyl, R²¹⁰ is hydrogen,

R²¹¹ is hydrogen, halogen, especially F, or Cl; nitro, cyano, C₁-C₄alkyl, C₁-C₄alkoxy, C₂-C₄alkenyl, C₁-C₄ perfluoroalkyl, —O—C₁-C₄ perfluoroalkyl, tri(C₁-C₄alkyl)silanyl, especially tri(methyl)silanyl, optionally substituted C₆-C₁₀aryl, especially phenyl, or optionally substituted C₆-C₁₀perfluoroaryl, especially C₆F₅,

R²¹² is hydrogen, halogen, especially F, or Cl; nitro, hydroxy, mercapto, amino, C₁-C₄alkyl, C₂-C₄alkenyl, C₁-C₄ perfluoroalkyl, C₁-C₄alkoxy, —O—C₁-C₄ perfluoroalkyl, —S—C₁-C₄alkyl, tri(C₁-C₄alkyl)siloxanyl, optionally substituted —O—C₆-C₁₀aryl, especially phenoxy, cyclohexyl, optionally substituted C₆-C₁₀aryl, especially phenyl, or optionally substituted C₆-C₁₀perfluoroaryl, especially C₆F₅, and

R²¹³ is hydrogen, nitro, cyano, C₁-C₄alkyl, C₂-C₄alkenyl, C₁-C₄ perfluoroalkyl, —O—C₁-C₄perfluoroalkyl, tri(C₁-C₄alkyl)silanyl, or optionally substituted C₆-C₁₀aryl, especially phenyl.

Specific examples of bidentate ligands L are the following compounds (X-1) to (X-57):

In case of the metal complex (L^(a))₂IrL′ three isomers can exist.

In some cases mixtures of isomers are obtained. Often the mixture can be used without isolating the individual isomers. The isomers can be separated by conventional methods, as described in A. B. Tamayo et al., J. Am. Chem. Soc. 125 (2003) 7377-7387.

The at present most preferred ligands L are listed below:

In a preferred embodiment the present invention is directed to compounds of formula Va, or Vb, wherein M² is Rh, or Re, especially Ir,

R² and R³ are independently of each other H, C₁-C₈ perfluoroalkyl, especially CF₃, or CN,

R⁶ is H, —NR²⁵R²⁶, or C₁-C₁₈alkoxy, wherein R²⁵ and R²⁶ are independently of each other C₁-C₁₈alkyl, or phenyl, which may be substituted by one, or more groups C₁-C₁₈alkoxy, or C₁-C₁₈alkyl, and L is a bidentate ligand.

In another preferred embodiment the present invention is directed to compounds of formula VIIa, or VIIb, wherein M⁴ is Pd, especially Pt,

R² and R³ are independently of each other H, C₁-C₈ perfluoroalkyl, especially CF₃, or CN,

R⁶ is H, —NR²⁵R²⁶, or C₁-C₁₈alkoxy, wherein R²⁵ and R²⁶ are independently of each other C₁-C₁₈alkyl, or phenyl, which may be substituted by one, or more groups C₁-C₁₈alkoxy, or C₁-C₁₈alkyl, and L is a bidentate ligand.

Preferences for the bidentate ligand L are given above, wherein the following ligands L are advantageously used:

A compound of formulae shown below:

wherein Cpd. R² R³ R⁶ A-1 H H H A-2 H H OCH₃ A-3 H H OCH₂CH₃ A-4 H H O-n-butyl A-5 H H O-iso-butyl A-6 H H O-2-butyl A-7 H H O-2-ethylhexyl A-8 H H N(CH₃)₂ A-9 H H NPh₂ A-10 H CF₃ H A-11 CF₃ H H A-12 H CF₃ OCH₃ A-13 CF₃ H OCH₃ A-14 H CF₃ OCH₂CH₃ A-15 CF₃ H OCH₂CH₃ A-16 H CF₃ O-n-butyl A-17 CF₃ H O-n-butyl A-18 H CF₃ O-iso-butyl A-19 CF₃ H O-iso-butyl A-20 H CF₃ O-2-butyl A-21 CF₃ H O-2-butyl A-22 H CF₃ O-2-ethylhexyl A-23 CF₃ H O-2-ethylhexyl A-24 H CF₃ N(CH₃)₂ A-25 CF₃ H N(CH₃)₂ A-26 H CF₃ NPh₂ A-27 CF₃ H NPh₂ A-28 H CN H A-29 CN H H A-30 H CN OCH₃ A-31 CN H OCH₂CH₃ A-32 H CN OCH₂CH₃ A-33 CN H O-n-butyl A-34 H CN O-n-butyl A-35 CN H O-iso-butyl A-36 H CN O-iso-butyl A-37 CN H O-2-butyl A-38 H CN O-2-butyl A-39 CN H O-2-ethylhexyl A-40 H CN O-2-ethylhexyl A-41 CN H N(CH₃)₂ A-42 H CN N(CH₃)₂ A-43 CN H NPh₂ A-44 H CN NPh₂

wherein Cpd. L′ R² R³ R⁶ B-1 A¹⁾ H H H B-2 A¹⁾ H H OCH₃ B-3 A¹⁾ H H OCH₂CH₃ B-4 A¹⁾ H H O-n-butyl B-5 A¹⁾ H H O-iso-butyl B-6 A¹⁾ H H O-2-butyl B-7 A¹⁾ H H O-2-ethylhexyl B-8 A¹⁾ H H N(CH₃)₂ B-9 A¹⁾ H H NPh₂ B-10 A¹⁾ H CF₃ H B-11 A¹⁾ CF₃ H H B-12 A¹⁾ H CF₃ OCH₃ B-13 A¹⁾ CF₃ H OCH₃ B-14 A¹⁾ H CF₃ OCH₂CH₃ B-15 A¹⁾ CF₃ H OCH₂CH₃ B-16 A¹⁾ H CF₃ O-n-butyl B-17 A¹⁾ CF₃ H O-n-butyl B-18 A¹⁾ H CF₃ O-iso-butyl B-19 A¹⁾ CF₃ H O-iso-butyl B-20 A¹⁾ H CF₃ O-2-butyl B-21 A¹⁾ CF₃ H O-2-butyl B-22 A¹⁾ H CF₃ O-2-ethylhexyl B-23 A¹⁾ CF₃ H O-2-ethylhexyl B-24 A¹⁾ H CF₃ N(CH₃)₂ B-25 A¹⁾ CF₃ H N(CH₃)₂ B-26 A¹⁾ H CF₃ NPh₂ B-27 A¹⁾ CF₃ H NPh₂ B-28 A¹⁾ H CN H B-29 A¹⁾ CN H H B-30 A¹⁾ CN H OCH₃ B-31 A¹⁾ H CN OCH₃ B-32 A¹⁾ CN H OCH₂CH₃ B-33 A¹⁾ H CN OCH₂CH₃ B-34 A¹⁾ CN H O-n-butyl B-35 A¹⁾ H CN O-n-butyl B-36 A¹⁾ CN H O-iso-butyl B-37 A¹⁾ H CN O-iso-butyl B-38 A¹⁾ CN H O-2-butyl B-39 A¹⁾ H CN O-2-butyl B-40 A¹⁾ CN H O-2-ethylhexyl B-41 A¹⁾ H CN O-2-ethylhexyl B-42 A¹⁾ CN H N(CH₃)₂ B-43 A¹⁾ H CN N(CH₃)₂ B-44 A¹⁾ CN H NPh₂ B-45 A¹⁾ H CN NPh₂ B-46 B¹⁾ H H H B-47 B¹⁾ H H OCH₃ B-48 B¹⁾ H H OCH₂CH₃ B-49 B¹⁾ H H O-n-butyl B-50 B¹⁾ H H O-iso-butyl B-51 B¹⁾ H H O-2-butyl B-52 B¹⁾ H H O-2-ethylhexyl B-53 B¹⁾ H H N(CH₃)₂ B-54 B¹⁾ H H NPh₂ B-55 B¹⁾ H CF₃ H B-56 B¹⁾ CF₃ H H B-57 B¹⁾ H CF₃ OCH₃ B-58 B¹⁾ CF₃ H OCH₃ B-59 B¹⁾ H CF₃ OCH₂CH₃ B-60 B¹⁾ CF₃ H OCH₂CH₃ B-61 B¹⁾ H CF₃ O-n-butyl B-62 B¹⁾ CF₃ H O-n-butyl B-63 B¹⁾ H CF₃ O-iso-butyl B-64 B¹⁾ CF₃ H O-iso-butyl B-65 B¹⁾ H CF₃ O-2-butyl B-66 B¹⁾ CF₃ H O-2-butyl B-67 B¹⁾ H CF₃ O-2-ethylhexyl B-68 B¹⁾ CF₃ H O-2-ethylhexyl B-69 B¹⁾ H CF₃ N(CH₃)₂ B-70 B¹⁾ CF₃ H N(CH₃)₂ B-71 B¹⁾ H CF₃ NPh₂ B-72 B¹⁾ CF₃ H NPh₂ B-73 B¹⁾ H CN H B-74 B¹⁾ CN H H B-75 B¹⁾ CN H OCH₃ B-76 B¹⁾ H CN OCH₃ B-77 B¹⁾ CN H OCH₂CH₃ B-78 B¹⁾ H CN OCH₂CH₃ B-79 B¹⁾ CN H O-n-butyl B-80 B¹⁾ H CN O-n-butyl B-81 B¹⁾ CN H O-iso-butyl B-82 B¹⁾ H CN O-iso-butyl B-83 B¹⁾ CN H O-2-butyl B-84 B¹⁾ H CN O-2-butyl B-85 B¹⁾ CN H O-2-ethylhexyl B-86 B¹⁾ H CN O-2-ethylhexyl B-87 B¹⁾ CN H N(CH₃)₂ B-88 B¹⁾ H CN N(CH₃)₂ B-89 B¹⁾ CN H NPh₂ B-99 B¹⁾ H CN NPh₂ B-100 C¹⁾ H H H B-101 C¹⁾ H H OCH₃ B-102 C¹⁾ H H OCH₂CH₃ B-103 C¹⁾ H H O-n-butyl B-104 C¹⁾ H H O-iso-butyl B-105 C¹⁾ H H O-2-butyl B-106 C¹⁾ H H O-2-ethylhexyl B-107 C¹⁾ H H N(CH₃)₂ B-108 C¹⁾ H H NPh₂ B-109 C¹⁾ H CF₃ H B-110 C¹⁾ CF₃ H H B-111 C¹⁾ H CF₃ OCH₃ B-112 C¹⁾ CF₃ H OCH₃ B-113 C¹⁾ H CF₃ OCH₂CH₃ B-114 C¹⁾ CF₃ H OCH₂CH₃ B-115 C¹⁾ H CF₃ O-n-butyl B-116 C¹⁾ CF₃ H O-n-butyl B-117 C¹⁾ H CF₃ O-iso-butyl B-118 C¹⁾ CF₃ H O-iso-butyl B-119 C¹⁾ H CF₃ O-2-butyl B-120 C¹⁾ CF₃ H O-2-butyl B-121 C¹⁾ H CF₃ O-2-ethylhexyl B-122 C¹⁾ CF₃ H O-2-ethylhexyl B-123 C¹⁾ H CF₃ N(CH₃)₂ B-124 C¹⁾ CF₃ H N(CH₃)₂ B-125 C¹⁾ H CF₃ NPh₂ B-126 C¹⁾ CF₃ H NPh₂ B-127 C¹⁾ H CN H B-128 C¹⁾ CN H H B-129 C¹⁾ CN H OCH₃ B-130 C¹⁾ H CN OCH₃ B-131 C¹⁾ CN H OCH₂CH₃ B-132 C¹⁾ H CN OCH₂CH₃ B-133 C¹⁾ CN H O-n-butyl B-134 C¹⁾ H CN O-n-butyl B-135 C¹⁾ CN H O-iso-butyl B-136 C¹⁾ H CN O-iso-butyl B-137 C¹⁾ CN H O-2-butyl B-138 C¹⁾ H CN O-2-butyl B-139 C¹⁾ CN H O-2-ethylhexyl B-140 C¹⁾ H CN O-2-ethylhexyl B-141 C¹⁾ CN H N(CH₃)₂ B-142 C¹⁾ H CN N(CH₃)₂ B-143 C¹⁾ H CN NPh₂ B-144 C¹⁾ CN H NPh₂ B-145 D¹⁾ H H H B-146 D¹⁾ H H OCH₃ B-147 D¹⁾ H H OCH₂CH₃ B-148 D¹⁾ H H O-n-butyl B-149 D¹⁾ H H O-iso-butyl B-150 D¹⁾ H H O-2-butyl B-151 D¹⁾ H H O-2-ethylhexyl B-152 D¹⁾ H H N(CH₃)₂ B-153 D¹⁾ H H NPh₂ B-154 D¹⁾ H CF₃ H B-155 D¹⁾ CF₃ H H B-156 D¹⁾ H CF₃ OCH₃ B-157 D¹⁾ CF₃ H OCH₃ B-158 D¹⁾ H CF₃ OCH₂CH₃ B-159 D¹⁾ CF₃ H OCH₂CH₃ B-160 D¹⁾ H CF₃ O-n-butyl B-161 D¹⁾ CF₃ H O-n-butyl B-162 D¹⁾ H CF₃ O-iso-butyl B-163 D¹⁾ CF₃ H O-iso-butyl B-164 D¹⁾ H CF₃ O-2-butyl B-165 D¹⁾ CF₃ H O-2-butyl B-166 D¹⁾ H CF₃ O-2-ethylhexyl B-167 D¹⁾ CF₃ H O-2-ethylhexyl B-168 D¹⁾ H CF₃ N(CH₃)₂ B-169 D¹⁾ CF₃ H N(CH₃)₂ B-170 D¹⁾ H CF₃ NPh₂ B-171 D¹⁾ CF₃ H NPh₂ B-172 D¹⁾ H CN H B-173 D¹⁾ CN H H B-174 D¹⁾ CN H OCH₃ B-175 D¹⁾ H CN OCH₃ B-176 D¹⁾ CN H OCH₂CH₃ B-177 D¹⁾ H CN OCH₂CH₃ B-178 D¹⁾ CN H O-n-butyl B-179 D¹⁾ H CN O-n-butyl B-180 D¹⁾ CN H O-iso-butyl B-181 D¹⁾ H CN O-iso-butyl B-182 D¹⁾ CN H O-2-butyl B-183 D¹⁾ H CN O-2-butyl B-184 D¹⁾ CN H O-2-ethylhexyl B-185 D¹⁾ H CN O-2-ethylhexyl B-186 D¹⁾ CN H N(CH₃)₂ B-187 D¹⁾ H CN N(CH₃)₂ B-188 D¹⁾ CN H NPh₂ B-189 D¹⁾ H CN NPh₂ B-190 E¹⁾ H H H B-191 E¹⁾ H H OCH₃ B-192 E¹⁾ H H OCH₂CH₃ B-193 E¹⁾ H H O-n-butyl B-194 E¹⁾ H H O-iso-butyl B-195 E¹⁾ H H O-2-butyl B-196 E¹⁾ H H O-2-ethylhexyl B-197 E¹⁾ H H N(CH₃)₂ B-198 E¹⁾ H H NPh₂ B-199 E¹⁾ H CF₃ H B-200 E¹⁾ CF₃ H H B-201 E¹⁾ H CF₃ OCH₃ B-202 E¹⁾ CF₃ H OCH₃ B-203 E¹⁾ H CF₃ OCH₂CH₃ B-204 E¹⁾ CF₃ H OCH₂CH₃ B-205 E¹⁾ H CF₃ O-n-butyl B-206 E¹⁾ CF₃ H O-n-butyl B-207 E¹⁾ H CF₃ O-iso-butyl B-208 E¹⁾ CF₃ H O-iso-butyl B-209 E¹⁾ H CF₃ O-2-butyl B-210 E¹⁾ CF₃ H O-2-butyl B-211 E¹⁾ H CF₃ O-2-ethylhexyl B-212 E¹⁾ CF₃ H O-2-ethylhexyl B-213 E¹⁾ H CF₃ N(CH₃)₂ B-214 E¹⁾ CF₃ H N(CH₃)₂ B-215 E¹⁾ H CF₃ NPh₂ B-216 E¹⁾ CF₃ H NPh₂ B-217 E¹⁾ H CN H B-218 E¹⁾ CN H H B-219 E¹⁾ CN H OCH₃ B-220 E¹⁾ H CN OCH₃ B-221 E¹⁾ CN H OCH₂CH₃ B-222 E¹⁾ H CN OCH₂CH₃ B-223 E¹⁾ CN H O-n-butyl B-224 E¹⁾ H CN O-n-butyl B-225 E¹⁾ CN H O-iso-butyl B-226 E¹⁾ H CN O-iso-butyl B-227 E¹⁾ CN H O-2-butyl B-228 E¹⁾ H CN O-2-butyl B-229 E¹⁾ CN H O-2-ethylhexyl B-230 E¹⁾ H CN O-2-ethylhexyl B-231 E¹⁾ CN H N(CH₃)₂ B-232 E¹⁾ H CN N(CH₃)₂ B-233 E¹⁾ CN H NPh₂ B-234 E¹⁾ H CN NPh₂

wherein Cpd. R² R³ R⁶ C-1 H H H C-2 H H OCH₃ C-3 H H OCH₂CH₃ C-4 H H O-n-butyl C-5 H H O-iso-butyl C-6 H H O-2-butyl C-7 H H O-2-ethylhexyl C-8 H H N(CH₃)₂ C-9 H H NPh₂ C-10 H CF₃ H C-11 CF₃ H H C-12 H CF₃ OCH₃ C-13 CF₃ H OCH₃ C-14 H CF₃ OCH₂CH₃ C-15 CF₃ H OCH₂CH₃ C-16 H CF₃ O-n-butyl C-17 CF₃ H O-n-butyl C-18 H CF₃ O-iso-butyl C-19 CF₃ H O-iso-butyl C-20 H CF₃ O-2-butyl C-21 CF₃ H O-2-butyl C-22 H CF₃ O-2-ethylhexyl C-23 CF₃ H O-2-ethylhexyl C-24 H CF₃ N(CH₃)₂ C-25 CF₃ H N(CH₃)₂ C-26 H CF₃ NPh₂ C-27 CF₃ H NPh₂ C-28 H CN H C-29 CN H H C-30 H CN OCH₃ C-31 CN H OCH₂CH₃ C-32 H CN OCH₂CH₃ C-33 CN H O-n-butyl C-34 H CN O-n-butyl C-35 CN H O-iso-butyl C-36 H CN O-iso-butyl C-37 CN H O-2-butyl C-38 H CN O-2-butyl C-39 CN H O-2-ethylhexyl C-40 H CN O-2-ethylhexyl C-41 CN H N(CH₃)₂ C-42 H CN N(CH₃)₂ C-43 CN H NPh₂ C-44 H CN NPh₂

wherein Cpd. L′ R² R³ R⁶ D-1 A¹⁾ H H H D-2 A¹⁾ H H OCH₃ D-3 A¹⁾ H H OCH₂CH₃ D-4 A¹⁾ H H O-n-butyl D-5 A¹⁾ H H O-iso-butyl D-6 A¹⁾ H H O-2-butyl D-7 A¹⁾ H H O-2-ethylhexyl D-8 A¹⁾ H H N(CH₃)₂ D-9 A¹⁾ H H NPh₂ D-10 A¹⁾ H CF₃ H D-11 A¹⁾ CF₃ H H D-12 A¹⁾ H CF₃ OCH₃ D-13 A¹⁾ CF₃ H OCH₃ D-14 A¹⁾ H CF₃ OCH₂CH₃ D-15 A¹⁾ CF₃ H OCH₂CH₃ D-16 A¹⁾ H CF₃ O-n-butyl D-17 A¹⁾ CF₃ H O-n-butyl D-18 A¹⁾ H CF₃ O-iso-butyl D-19 A¹⁾ CF₃ H O-iso-butyl D-20 A¹⁾ H CF₃ O-2-butyl D-21 A¹⁾ CF₃ H O-2-butyl D-22 A¹⁾ H CF₃ O-2-ethylhexyl D-23 A¹⁾ CF₃ H O-2-ethylhexyl D-24 A¹⁾ H CF₃ N(CH₃)₂ D-25 A¹⁾ CF₃ H N(CH₃)₂ D-26 A¹⁾ H CF₃ NPh₂ D-27 A¹⁾ CF₃ H NPh₂ D-28 A¹⁾ H CN H D-29 A¹⁾ CN H H D-30 A¹⁾ CN H OCH₃ D-31 A¹⁾ H CN OCH₃ D-32 A¹⁾ CN H OCH₂CH₃ D-33 A¹⁾ H CN OCH₂CH₃ D-34 A¹⁾ CN H O-n-butyl D-35 A¹⁾ H CN O-n-butyl D-36 A¹⁾ CN H O-iso-butyl D-37 A¹⁾ H CN O-iso-butyl D-38 A¹⁾ CN H O-2-butyl D-39 A¹⁾ H CN O-2-butyl D-40 A¹⁾ CN H O-2-ethylhexyl D-41 A¹⁾ H CN O-2-ethylhexyl D-42 A¹⁾ CN H N(CH₃)₂ D-43 A¹⁾ H CN N(CH₃)₂ D-44 A¹⁾ CN H NPh₂ D-45 A¹⁾ H CN NPh₂ D-46 B¹⁾ H H H D-47 B¹⁾ H H OCH₃ D-48 B¹⁾ H H OCH₂CH₃ D-49 B¹⁾ H H O-n-butyl D-50 B¹⁾ H H O-iso-butyl D-51 B¹⁾ H H O-2-butyl D-52 B¹⁾ H H O-2-ethylhexyl D-53 B¹⁾ H H N(CH₃)₂ D-54 B¹⁾ H H NPh₂ D-55 B¹⁾ H CF₃ H D-56 B¹⁾ CF₃ H H D-57 B¹⁾ H CF₃ OCH₃ D-58 B¹⁾ CF₃ H OCH₃ D-59 B¹⁾ H CF₃ OCH₂CH₃ D-60 B¹⁾ CF₃ H OCH₂CH₃ D-61 B¹⁾ H CF₃ O-n-butyl D-62 B¹⁾ CF₃ H O-n-butyl D-63 B¹⁾ H CF₃ O-iso-butyl D-64 B¹⁾ CF₃ H O-iso-butyl D-65 B¹⁾ H CF₃ O-2-butyl D-66 B¹⁾ CF₃ H O-2-butyl D-67 B¹⁾ H CF₃ O-2-ethylhexyl D-68 B¹⁾ CF₃ H O-2-ethylhexyl D-69 B¹⁾ H CF₃ N(CH₃)₂ D-70 B¹⁾ CF₃ H N(CH₃)₂ D-71 B¹⁾ H CF₃ NPh₂ D-72 B¹⁾ CF₃ H NPh₂ D-73 B¹⁾ H CN H D-74 B¹⁾ CN H H D-75 B¹⁾ CN H OCH₃ D-76 B¹⁾ H CN OCH₃ D-77 B¹⁾ CN H OCH₂CH₃ D-78 B¹⁾ H CN OCH₂CH₃ D-79 B¹⁾ CN H O-n-butyl D-80 B¹⁾ H CN O-n-butyl D-81 B¹⁾ CN H O-iso-butyl D-82 B¹⁾ H CN O-iso-butyl D-83 B¹⁾ CN H O-2-butyl D-84 B¹⁾ H CN O-2-butyl D-85 B¹⁾ CN H O-2-ethylhexyl D-86 B¹⁾ H CN O-2-ethylhexyl D-87 B¹⁾ CN H N(CH₃)₂ D-88 B¹⁾ H CN N(CH₃)₂ D-89 B¹⁾ CN H NPh₂ D-99 B¹⁾ H CN NPh₂ D-100 C¹⁾ H H H D-101 C¹⁾ H H OCH₃ D-102 C¹⁾ H H OCH₂CH₃ D-103 C¹⁾ H H O-n-butyl D-104 C¹⁾ H H O-iso-butyl D-105 C¹⁾ H H O-2-butyl D-106 C¹⁾ H H O-2-ethylhexyl D-107 C¹⁾ H H N(CH₃)₂ D-108 C¹⁾ H H NPh₂ D-109 C¹⁾ H CF₃ H D-110 C¹⁾ CF₃ H H D-111 C¹⁾ H CF₃ OCH₃ D-112 C¹⁾ CF₃ H OCH₃ D-113 C¹⁾ H CF₃ OCH₂CH₃ D-114 C¹⁾ CF₃ H OCH₂CH₃ D-115 C¹⁾ H CF₃ O-n-butyl D-116 C¹⁾ CF₃ H O-n-butyl D-117 C¹⁾ H CF₃ O-iso-butyl D-118 C¹⁾ CF₃ H O-iso-butyl D-119 C¹⁾ H CF₃ O-2-butyl D-120 C¹⁾ CF₃ H O-2-butyl D-121 C¹⁾ H CF₃ O-2-ethylhexyl D-122 C¹⁾ CF₃ H O-2-ethylhexyl D-123 C¹⁾ H CF₃ N(CH₃)₂ D-124 C¹⁾ CF₃ H N(CH₃)₂ D-125 C¹⁾ H CF₃ NPh₂ D-126 C¹⁾ CF₃ H NPh₂ D-127 C¹⁾ H CN H D-128 C¹⁾ CN H H D-129 C¹⁾ CN H OCH₃ D-130 C¹⁾ H CN OCH₃ D-131 C¹⁾ CN H OCH₂CH₃ D-132 C¹⁾ H CN OCH₂CH₃ D-133 C¹⁾ CN H O-n-butyl D-134 C¹⁾ H CN O-n-butyl D-135 C¹⁾ CN H O-iso-butyl D-136 C¹⁾ H CN O-iso-butyl D-137 C¹⁾ CN H O-2-butyl D-138 C¹⁾ H CN O-2-butyl D-139 C¹⁾ CN H O-2-ethylhexyl D-140 C¹⁾ H CN O-2-ethylhexyl D-141 C¹⁾ CN H N(CH₃)₂ D-142 C¹⁾ H CN N(CH₃)₂ D-143 C¹⁾ H CN NPh₂ D-144 C¹⁾ CN H NPh₂ D-145 D¹⁾ H H H D-146 D¹⁾ H H OCH₃ D-147 D¹⁾ H H OCH₂CH₃ D-148 D¹⁾ H H O-n-butyl D-149 D¹⁾ H H O-iso-butyl D-150 D¹⁾ H H O-2-butyl D-151 D¹⁾ H H O-2-ethylhexyl D-152 D¹⁾ H H N(CH₃)₂ D-153 D¹⁾ H H NPh₂ D-154 D¹⁾ H CF₃ H D-155 D¹⁾ CF₃ H H D-156 D¹⁾ H CF₃ OCH₃ D-157 D¹⁾ CF₃ H OCH₃ D-158 D¹⁾ H CF₃ OCH₂CH₃ D-159 D¹⁾ CF₃ H OCH₂CH₃ D-160 D¹⁾ H CF₃ O-n-butyl D-161 D¹⁾ CF₃ H O-n-butyl D-162 D¹⁾ H CF₃ O-iso-butyl D-163 D¹⁾ CF₃ H O-iso-butyl D-164 D¹⁾ H CF₃ O-2-butyl D-165 D¹⁾ CF₃ H O-2-butyl D-166 D¹⁾ H CF₃ O-2-ethylhexyl D-167 D¹⁾ CF₃ H O-2-ethylhexyl D-168 D¹⁾ H CF₃ N(CH₃)₂ D-169 D¹⁾ CF₃ H N(CH₃)₂ D-170 D¹⁾ H CF₃ NPh₂ D-171 D¹⁾ CF₃ H NPh₂ D-172 D¹⁾ H CN H D-173 D¹⁾ CN H H D-174 D¹⁾ CN H OCH₃ D-175 D¹⁾ H CN OCH₃ D-176 D¹⁾ CN H OCH₂CH₃ D-177 D¹⁾ H CN OCH₂CH₃ D-178 D¹⁾ CN H O-n-butyl D-179 D¹⁾ H CN O-n-butyl D-180 D¹⁾ CN H O-iso-butyl D-181 D¹⁾ H CN O-iso-butyl D-182 D¹⁾ CN H O-2-butyl D-183 D¹⁾ H CN O-2-butyl D-184 D¹⁾ CN H O-2-ethylhexyl D-185 D¹⁾ H CN O-2-ethylhexyl D-186 D¹⁾ CN H N(CH₃)₂ D-187 D¹⁾ H CN N(CH₃)₂ D-188 D¹⁾ CN H NPh₂ D-189 D¹⁾ H CN NPh₂ D-190 F¹⁾ H H H D-191 F¹⁾ H H OCH₃ D-192 F¹⁾ H H OCH₂CH₃ D-193 F¹⁾ H H O-n-butyl D-194 F¹⁾ H H O-iso-butyl D-195 F¹⁾ H H O-2-butyl D-196 F¹⁾ H H O-2-ethylhexyl D-197 F¹⁾ H H N(CH₃)₂ D-198 F¹⁾ H H NPh₂ D-199 F¹⁾ H CF₃ H D-200 F¹⁾ CF₃ H H D-201 F¹⁾ H CF₃ OCH₃ D-202 F¹⁾ CF₃ H OCH₃ D-203 F¹⁾ H CF₃ OCH₂CH₃ D-204 F¹⁾ CF₃ H OCH₂CH₃ D-205 F¹⁾ H CF₃ O-n-butyl D-206 F¹⁾ CF₃ H O-n-butyl D-207 F¹⁾ H CF₃ O-iso-butyl D-208 F¹⁾ CF₃ H O-iso-butyl D-209 F¹⁾ H CF₃ O-2-butyl D-210 F¹⁾ CF₃ H O-2-butyl D-211 F¹⁾ H CF₃ O-2-ethylhexyl D-212 F¹⁾ CF₃ H O-2-ethylhexyl D-213 F¹⁾ H CF₃ N(CH₃)₂ D-214 F¹⁾ CF₃ H N(CH₃)₂ D-215 F¹⁾ H CF₃ NPh₂ D-216 F¹⁾ CF₃ H NPh₂ D-217 F¹⁾ H CN H D-218 F¹⁾ CN H H D-219 F¹⁾ CN H OCH₃ D-220 F¹⁾ H CN OCH₃ D-221 F¹⁾ CN H OCH₂CH₃ D-222 F¹⁾ H CN OCH₂CH₃ D-223 F¹⁾ CN H O-n-butyl D-224 F¹⁾ H CN O-n-butyl D-225 F¹⁾ CN H O-iso-butyl D-226 F¹⁾ H CN O-iso-butyl D-227 F¹⁾ CN H O-2-butyl D-228 F¹⁾ H CN O-2-butyl D-229 F¹⁾ CN H O-2-ethylhexyl D-230 F¹⁾ H CN O-2-ethylhexyl D-231 F¹⁾ CN H N(CH₃)₂ D-232 F¹⁾ H CN N(CH₃)₂ D-233 F¹⁾ CN H NPh₂ D-234 F¹⁾ H CN NPh₂ D-235 E¹⁾ H H H D-236 E¹⁾ H H OCH₃ D-237 E¹⁾ H H OCH₂CH₃ D-238 E¹⁾ H H O-n-butyl D-239 E¹⁾ H H O-iso-butyl D-240 E¹⁾ H H O-2-butyl D-241 E¹⁾ H H O-2-ethylhexyl D-242 E¹⁾ H H N(CH₃)₂ D-243 E¹⁾ H H NPh₂ D-244 E¹⁾ H CF₃ H D-245 E¹⁾ CF₃ H H D-246 E¹⁾ H CF₃ OCH₃ D-247 E¹⁾ CF₃ H OCH₃ D-248 E¹⁾ H CF₃ OCH₂CH₃ D-249 E¹⁾ CF₃ H OCH₂CH₃ D-250 E¹⁾ H CF₃ O-n-butyl D-251 E¹⁾ CF₃ H O-n-butyl D-252 E¹⁾ H CF₃ O-iso-butyl D-253 E¹⁾ CF₃ H O-iso-butyl D-254 E¹⁾ H CF₃ O-2-butyl D-255 E¹⁾ CF₃ H O-2-butyl D-256 E¹⁾ H CF₃ O-2-ethylhexyl D-257 E¹⁾ CF₃ H O-2-ethylhexyl D-258 E¹⁾ H CF₃ N(CH₃)₂ D-259 E¹⁾ CF₃ H N(CH₃)₂ D-260 E¹⁾ H CF₃ NPh₂ D-261 E¹⁾ CF₃ H NPh₂ D-262 E¹⁾ H CN H D-263 E¹⁾ CN H H D-264 E¹⁾ CN H OCH₃ D-265 E¹⁾ H CN OCH₃ D-266 E¹⁾ CN H OCH₂CH₃ D-267 E¹⁾ H CN OCH₂CH₃ D-268 E¹⁾ CN H O-n-butyl D-269 E¹⁾ H CN O-n-butyl D-270 E¹⁾ CN H O-iso-butyl D-271 E¹⁾ H CN O-iso-butyl D-272 E¹⁾ CN H O-2-butyl D-273 E¹⁾ H CN O-2-butyl D-274 E¹⁾ CN H O-2-ethylhexyl D-275 E¹⁾ H CN O-2-ethylhexyl D-276 E¹⁾ CN H N(CH₃)₂ D-277 E¹⁾ H CN N(CH₃)₂ D-278 E¹⁾ CN H NPh₂ D-279 E¹⁾ H CN NPh₂ B-235 A¹⁾ CH₃ H H B-236 A¹⁾ H CH₃ H B-237 E¹⁾ CH₃ H H B-238 E¹⁾ H CH₃ H B-239 E¹⁾ H H OCH₃ B-240 A¹⁾ H H 2-propoxy B-241 E¹⁾ H H 2-propoxy B-242 D¹⁾ H H 2-propoxy B-243 F¹⁾ CF₃ H H B-244 F¹⁾ H CF₃ H B-245 F¹⁾ H H H B-246 F¹⁾ H H OCH₃ ¹⁾A =

B =

C =

D =

E =

F =

Examples of specific compounds of formula Va are compounds B-1 to B-89, B-99 to B-250, and B-254 to B-293. Special emphasis among them is given to compounds B-1, B-2, B-3, B-4, B-10, B-11, B-12, B-13, B-14, B-15, B-16, B-17, B-190, B-191, B-192, B-193, B-199, B-200, B-201, B-202, B-203 and B-204. Examples of specific compounds of formula Vb are compounds A-1 to A 44. Special emphasis among them is given to compounds A-1, A-2, A-3, A-4, A-10, A-11, A-12 and A-13. Examples of specific compounds of formula VIa are compounds E-1 to E 5.

Examples of specific compounds of formula VIIa are compounds D-1 to D-89 and D-99 to D-279. Special emphasis among them is given to compounds D-1, D-2, D-3, D-4, D-10, D11, D-12, D-13, D-235, D-236, D-244, D-245, D-246 and D-247. Examples of specific compounds of formula VIIb are compounds C-1 to C-44. Special emphasis among them is given to compounds C-1, C-2, C-10, C-11, C-12 and C-13.

The metal complexes of the present invention can be prepared according to usual methods known in the prior art. A convenient one-step method for preparing iridium metal complexes of formula Ir(La)₃

comprises reacting commercially available iridium trichloride hydrate with an excess of L^(a)H in the presence of 3 equivalents silver trifluoroacetate and optionally in the presence of a solvent (such as halogen based solvents, alcohol based solvents, ether based solvents, ester based solvents, ketone based solvents, nitrile based solvents, and water). The tris-cyclometalated iridium complexes are isolated and purified by conventional methods. In some cases mixtures of isomers are obtained. Often the mixture can be used without isolating the individual isomers.

The iridium metal complexes of formula Ir(La)₂L can, for example be prepared by first preparing an intermediate iridium dimer of formula

wherein X is H, methyl, or ethyl, and L^(a) is as defined above, and then addition of HL. The iridium dimers can generally be prepared by first reacting iridium trichloride hydrate with HL^(a) and adding NaX and by reacting iridium trichloride hydrate with HL^(a) in a suitable solvent, such as 2-ethoxyethanol. The compounds of formula

are new and form a further aspect of the present invention. Compounds of formula VIIa and VIIb can be synthesized, for example, as outlined in FIGS. 7 and 8 of U.S. Pat. No. 7,166,368.

Halogen is fluorine, chlorine, bromine and iodine.

C₁-C₂₄alkyl is a branched or unbranched radical such as for example methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, 2-ethylbutyl, n-pentyl, isopentyl, 1-methylpentyl, 1,3-dimethylbutyl, n-hexyl, 1-methylhexyl, n-heptyl, isoheptyl, 1,1,3,3-tetramethylbutyl, 1-methylheptyl, 3-methylheptyl, n-octyl, 2-ethylhexyl, 1,1,3-trimethylhexyl, 1,1,3,3-tetramethylpentyl, nonyl, decyl, undecyl, 1-methylundecyl, dodecyl, 1,1,3,3,5,5-hexamethylhexyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, icosyl or docosyl.

C₁-C₂₄ perfluoroalkyl is a branched or unbranched radical such as for example —CF₃, —CF₂CF₃, —CF₂CF₂CF₃, —CF(CF₃)₂, —(CF₂)₃CF₃, and —C(CF₃)₃.

C₁-C₂₄alkoxy radicals are straight-chain or branched alkoxy radicals, e.g. methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, sec-butoxy, tert-butoxy, amyloxy, isoamyloxy or tert-amyloxy, heptyloxy, octyloxy, isooctyloxy, nonyloxy, decyloxy, undecyloxy, dodecyloxy, tetradecyloxy, pentadecyloxy, hexadecyloxy, heptadecyloxy and octadecyloxy.

C₂-C₂₄alkenyl radicals are straight-chain or branched alkenyl radicals, such as e.g. vinyl, allyl, methallyl, isopropenyl, 2-butenyl, 3-butenyl, isobutenyl, n-penta-2,4-dienyl, 3-methyl-but-2-enyl, n-oct-2-enyl, n-dodec-2-enyl, isododecenyl, n-dodec-2-enyl or n-octadec-4-enyl.

C₂₋₂₄alkynyl is straight-chain or branched and preferably C₂₋₈alkynyl, which may be unsubstituted or substituted, such as, for example, ethynyl, 1-propyn-3-yl, 1-butyn-4-yl, 1-pentyn-5-yl, 2-methyl-3-butyn-2-yl, 1,4-pentadiyn-3-yl, 1,3-pentadiyn-5-yl, 1-hexyn-6-yl, cis-3-methyl-2-penten-4-yn-1-yl, trans-3-methyl-2-penten-4-yn-1-yl, 1,3-hexadiyn-5-yl, 1-octyn-8-yl, 1-nonyn-9-yl, 1-decyn-10-yl, or 1-tetracosyn-24-yl.

C₄-C₁₈cycloalkyl, especially C₅-C₁₂cycloalkyl, is preferably C₅-C₁₂cycloalkyl or said cycloalkyl substituted by one to three C₁-C₄alkyl groups, such as, for example, cyclopentyl, methyl-cyclopentyl, dimethylcyclopentyl, cyclohexyl, methylcyclohexyl, dimethylcyclohexyl, trimethyl-cyclohexyl, tert-butylcyclohexyl, cycloheptyl, cyclooctyl, cyclononyl, cyclodecyl, cyclododecyl, 1-adamantyl, or 2-adamantyl. Cyclohexyl, 1-adamantyl and cyclopentyl are most preferred.

Examples of C₄-C₁₈cycloalkyl, which is interrupted by S, O, or NR²⁵, are piperidyl, piperazinyl and morpholinyl.

C₂-C₂₄alkenyl is for example vinyl, allyl, butenyl, pentenyl, hexenyl, heptenyl, or octenyl.

Aryl is usually C₆-C₃₀aryl, preferably C₆-C₂₄aryl, which optionally can be substituted, such as, for example, phenyl, 4-methylphenyl, 4-methoxyphenyl, naphthyl, biphenylyl, 2-fluorenyl, phenanthryl, anthryl, tetracyl, pentacyl, hexacyl, terphenylyl or quadphenylyl; or phenyl substituted by one to three C₁-C₄alkyl groups, for example o-, m- or p-methylphenyl, 2,3-dimethylphenyl, 2,4-dimethylphenyl, 2,5-dimethylphenyl, 2,6-dimethylphenyl, 3,4-dimethylphenyl, 3,5-dimethylphenyl, 2-methyl-6-ethylphenyl, 4-tert-butylphenyl, 2-ethylphenyl or 2,6-diethylphenyl.

C₇-C₂₄aralkyl radicals are preferably C₇-C₁₅aralkyl radicals, which may be substituted, such as, for example, benzyl, 2-benzyl-2-propyl, β-phenethyl, α-methylbenzyl, α,α-dimethylbenzyl, ω-phenyl-butyl, ω-phenyl-octyl, ω-phenyl-dodecyl; or phenyl-C₁-C₄alkyl substituted on the phenyl ring by one to three C₁-C₄alkyl groups, such as, for example, 2-methylbenzyl, 3-methylbenzyl, 4-methylbenzyl, 2,4-dimethylbenzyl, 2,6-dimethylbenzyl or 4-tert-butylbenzyl. or 3-methyl-5-(1′,1′,3′,3′-tetramethyl-butyl)-benzyl.

Heteroaryl is typically C₂-C₂₆heteroaryl, i.e. a ring with five to seven ring atoms or a condensed rig system, wherein nitrogen, oxygen or sulfur are the possible hetero atoms, and is typically an unsaturated heterocyclic radical with five to 30 atoms having at least six conjugated π-electrons such as thienyl, benzo[b]thienyl, dibenzo[b,d]thienyl, thianthrenyl, furyl, furfuryl, 2H-pyranyl, benzofuranyl, isobenzofuranyl, dibenzofuranyl, phenoxythienyl, pyrrolyl, imidazolyl, pyrazolyl, pyridyl, bipyridyl, triazinyl, pyrimidinyl, pyrazinyl, pyridazinyl, indolizinyl, isoindolyl, indolyl, indazolyl, purinyl, quinolizinyl, chinolyl, isochinolyl, phthalazinyl, naphthyridinyl, chinoxalinyl, chinazolinyl, cinnolinyl, pteridinyl, carbazolyl, carbolinyl, benzotriazolyl, benzoxazolyl, phenanthridinyl, acridinyl, perimidinyl, phenanthrolinyl, phenazinyl, isothiazolyl, phenothiazinyl, isoxazolyl, furazanyl or phenoxazinyl, which can be unsubstituted or substituted.

C₆-C₁₈cycloalkoxy is, for example, cyclopentyloxy, cyclohexyloxy, cycloheptyloxy or cyclooctyloxy, or said cycloalkoxy substituted by one to three C₁-C₄alkyl, for example, methylcyclopentyloxy, dimethylcyclopentyloxy, methylcyclohexyloxy, dimethylcyclohexyloxy, trimethylcyclohexyloxy, or tert-butylcyclohexyloxy.

C₆-C₂₄aryloxy is typically phenoxy or phenoxy substituted by one to three C₁-C₄alkyl groups, such as, for example o-, m- or p-methylphenoxy, 2,3-dimethylphenoxy, 2,4-dimethylphenoxy, 2,5-dimethylphenoxy, 2,6-dimethylphenoxy, 3,4-dimethylphenoxy, 3,5-dimethylphenoxy, 2-methyl-6-ethylphenoxy, 4-tert-butylphenoxy, 2-ethylphenoxy or 2,6-diethylphenoxy.

C₆-C₂₄aralkoxy is typically phenyl-C₁-C₉alkoxy, such as, for example, benzyloxy, α-methylbenzyloxy, α,α-dimethylbenzyloxy or 2-phenylethoxy.

C₁-C₂₄alkylthio radicals are straight-chain or branched alkylthio radicals, such as e.g. methylthio, ethylthio, propylthio, isopropylthio, n-butylthio, isobutylthio, pentylthio, isopentyl thio, hexylthio, heptylthio, octylthio, decylthio, tetradecylthio, hexadecylthio or octadecylthio. C₁-C₂₄alkylselenium and C₁-C₂₄alkyltellurium are C₁-C₂₄alkylSe— and C₁-C₂₄alkylTe—, respectively.

Examples of a five or six membered ring formed by R⁹ and R¹⁰ and R²⁵ and R²⁶, respectively are heterocycloalkanes or heterocycloalkenes having from 3 to 5 carbon atoms which can have one additional hetero atom selected from nitrogen, oxygen and sulfur, for example

which can be part of a bicyclic system, for example

Possible substituents of the above-mentioned groups are C₁-C₈alkyl, a hydroxyl group, a mercapto group, C₁-C₈alkoxy, C₁-C₈alkylthio, halogen, especially fluorine, halo-C₁-C₈alkyl, especially fluoro-C₁-C₈alkyl, a cyano group, an aldehyde group, a ketone group, a carboxyl group, an ester group, a carbamoyl group, an amino group, a nitro group or a silyl group.

The term “haloalkyl” means groups given by partially or wholly substituting the above-mentioned alkyl group with halogen, such as trifluoromethyl etc. The “aldehyde group, ketone group, ester group, carbamoyl group and amino group” include those substituted by an C₁-C₂₄alkyl group, a C₄-C₁₈cycloalkyl group, an C₆-C₃₀aryl group, an C₇-C₂₄aralkyl group or a heterocyclic group, wherein the alkyl group, the cycloalkyl group, the aryl group, the aralkyl group and the heterocyclic group may be unsubstituted or substituted. The term “silyl group” means a group of formula —SiR¹⁰⁵R¹⁰⁶R¹⁰⁷, wherein R¹⁰⁵, R¹⁰⁶ and R¹⁰⁷ are independently of each other a C₁-C₈alkyl group, in particular a C₁-C₄ alkyl group, a C₆-C₂₄aryl group or a C₇-C₁₂aralkyl group, such as a trimethylsilyl group.

If a substituent occurs more than one time in a group, it can be different in each occurrence.

The present invention is also directed to an electronic device comprising the metal complex and its fabrication process. The electronic device can comprise at least one organic active material positioned between two electrical contact layers, wherein at least one of the layers of the device includes the metallic complex compound. The electronic device can comprise an anode layer (a), a cathode layer (e), and an active layer (c). Adjacent to the anode layer (a) is an optional hole-injecting/transport layer (b), and adjacent to the cathode layer (e) is an optional electron-injection/transport layer (d). Layers (b) and (d) are examples of charge transport layers.

The active layer (c) can comprise at least approximately 1 weight percent of metal complex previously described.

In some embodiments, the active layer (c) may be substantially 100% of the metal complex because a host charge transporting material, such as Alq₃ is not needed. By “substantially 100%” it is meant that the metal complex is the only material in the layer, with the possible exception of impurities or adventitious by-products from the process to form the layer. Still, in some embodiments, the metal complex may be a dopant within a host material, which is typically used to aid charge transport within the active layer (c). The active layer (c), including any of the metal complexes, can be a small molecule active material.

The device may include a support or substrate (not shown) adjacent to the anode layer (a) or the cathode layer (e). Most frequently, the support is adjacent the anode layer (a). The support can be flexible or rigid, organic or inorganic. Generally, glass or flexible organic films are used as a support. The anode layer (a) is an electrode that is more efficient for injecting holes compared to the cathode layer (e). The anode can include materials containing a metal, mixed metal, alloy, metal oxide or mixed-metal oxide. Suitable metal elements within the anode layer (a) can include the Groups 4, 5, 6, and 8-11 transition metals. If the anode layer (a) is to be light transmitting, mixed-metal oxides of Groups 12, 13 and 14 metals, such as indium-tin-oxide, may be used. Some non-limiting, specific examples of materials for anode layer (a) include indium-tin-oxide (“ITO”), aluminum-tin-oxide, gold, silver, copper, nickel, and selenium.

The anode layer (a) may be formed by a chemical or physical vapor deposition process or spin-cast process. Chemical vapor deposition may be performed as a plasma-enhanced chemical vapor deposition (“PECVD”) or metal organic chemical vapor deposition (“MOCVD”).

Physical vapor deposition can include all forms of sputtering (e.g., ion beam sputtering), e-beam evaporation, and resistance evaporation.

Specific forms of physical vapor deposition include rf magnetron sputtering or inductively-coupled plasma physical vapor deposition (“ICP-PVD”). These deposition techniques are well-known within the semiconductor fabrication arts.

A hole-transport layer (b) may be adjacent the anode. Both hole transporting small molecule compounds and polymers can be used.

Commonly used hole transporting molecules, in addition to N,N′-diphenyl-N,N′-bis(3-methylphenyl)-[1,1′-biphenyl]-4,4′-diamine (TPD) and bis[4-(N,N-diethylamino)-2-methylphenyl] (4-methylphenyl)methane(MPMP), include: polyvinyl-carbazol, 1,1-bis[(di-4-tolylamino)phenyl]cyclohexane (TAPC); N,N′-bis(4-methylphenyl)-N,N′-bis(4-ethylphenyl)-[1,1,1-(3,3′-dimethyl)biphenyl]-4,4′-diamine (ETPD); tetrakis-(3-methylphenyl)-N,N,N′,N′-2,5-phenylenediamine (PDA); a-phenyl-4-N,N-diphenylaminostyrene (TPS); p-(diethylamino)benzaldehyde diphenylhydrazone (DEH); triphenylamine (TPA); 1-phenyl-3-[p-(diethylamino)styryl]-5-[p-(diethylamino)phenyl]pyrazoline (PPR or DEASP); 1,2-trans-bis(9H-carbazol-9-yl)cyclobutane (DCZB); N,N,N′,N′-tetrakis(4-methylphenyl)-(1,1′-biphenyl)-4,4′-diamine (TTB); N,N′-di-α-naphthyl-N,N′-diphenyl-4,4′-diphenyldiamine (α-NPD), and porphyrinic compounds, such as copper phthalocyanine.

Commonly used hole transporting polymers are polyvinylcarbazole, (phenylmethyl) polysilane, poly(3,4-ethylendioxythiophene) (PEDOT), and polyaniline. Hole-transporting polymers can be obtained by doping hole-transporting molecules such as those mentioned above into polymers such as polystyrene and polycarbonate.

The hole-injection/transport layer (b) can be formed using any conventional means, including spin-coating, casting, and printing, such as gravure printing. The layer can also be applied by ink jet printing, thermal patterning, or chemical, or physical vapor deposition.

Usually, the anode layer (a) and the hole-injection/transport layer (b) are patterned during the same lithographic operation. The pattern may vary as desired. The layers can be formed in a pattern by, for example, positioning a patterned mask or resist on the first flexible composite barrier structure prior to applying the first electrical contact layer material. Alternatively, the layers can be applied as an overall layer (also called blanket deposit) and subsequently patterned using, for example, a patterned resist layer and wet-chemical or dry-etching techniques. Other processes for patterning that are well known in the art can also be used. When the electronic devices are located within an array, the anode layer (a) and hole injection/transport layer (b) typically are formed into substantially parallel strips having lengths that extend in substantially the same direction.

The active layer (c) may comprise the metal complexes described herein. The particular material chosen may depend on the specific application, potentials used during operation, or other factors. The active layer (c) may comprise a host material capable of transporting electrons and/or holes, doped with an emissive material that may trap electrons, holes, and/or excitons, such that excitons relax from the emissive material via a photoemissive mechanism. Active layer (c) may comprise a single material that combines transport and emissive properties. Whether the emissive material is a dopant or a major constituent, the active layer may comprise other materials, such as dopants that tune the emission of the emissive material. Active layer (c) may include a plurality of emissive materials capable of, in combination, emitting a desired spectrum of light. Examples of phosphorescent emissive materials include the metal complexes of the present invention. Examples of fluorescent emissive materials include DCM and DMQA. Examples of host materials include Alq₃, BAlq, BAlq₂(Appl. Phys. Lett. 89 (2006) 061111), CBP and mCP. Examples of emissive and host materials are disclosed in U.S. Pat. No. 6,303,238, which is incorporated by reference in its entirety.

The active layer (c) can be applied from solutions by any conventional technique, including spin coating, casting, and printing. The active organic materials can be applied directly by vapor deposition processes, depending upon the nature of the materials.

Optional layer (d) can function both to facilitate electron injection/transport, and also serve as a buffer layer or confinement layer to prevent quenching reactions at layer interfaces. More specifically, layer (d) may promote electron mobility and reduce the likelihood of a quenching reaction if layers (c) and (e) would otherwise be in direct contact. Examples of materials for optional layer (d) include metal-cheated oxinoid compounds (e.g., Alq₃ or the like); phenanthroline-based compounds (e.g., 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline (“DDPA”), 4,7-diphenyl-1,10-phenanthroline (“DPA”), or the like; azole compounds (e.g., 2-(4-biphenylyl)-5-(4-t-butylphenyl)-1,3,4-oxadiazole (“PBD”) or the like, 3-(4-biphenylyl)-4-phenyl-5-(4-t-butylphenyl)-1,2,4-triazole (“TAZ”) or the like; other similar compounds; or any one or more combinations thereof. Alternatively, optional layer (d) may be inorganic and comprise BaO, LiF, Li₂O, or the like.

The electron injection/transport layer (d) can be formed using any conventional means, including spin-coating, casting, and printing, such as gravure printing. The layer can also be applied by ink jet printing, thermal patterning, or chemical or physical vapor deposition.

The cathode layer (e) is an electrode that is particularly efficient for injecting electrons or negative charge carriers. The cathode layer (e) can be any metal or nonmetal having a lower work function than the first electrical contact layer (in this case, the anode layer (a)). Materials for the second electrical contact layer can be selected from alkali metals of Group 1 (e.g., Li, Na, K, Rb, Cs), the Group 2 (alkaline earth) metals, the Group 12 metals, the rare earths, the lanthanides (e.g., Ce, Sm, Eu, or the like), and the actinides. Materials, such as aluminum, indium, calcium, barium, yttrium, and magnesium, and combinations thereof, may also be used. Li-containing organometallic compounds, LiF, and Li₂O can also be deposited between the organic layer and the cathode layer to lower the operating voltage. Specific non-limiting examples of materials for the cathode layer (e) include barium, lithium, cerium, cesium, europium, rubidium, yttrium, magnesium, or samarium.

The cathode layer (e) is usually formed by a chemical or physical vapor deposition process. In general, the cathode layer will be patterned, as discussed above in reference to the anode layer (a) and optional hole injecting layer (b). If the device lies within an array, the cathode layer (e) may be patterned into substantially parallel strips, where the lengths of the cathode layer strips extend in substantially the same direction and substantially perpendicular to the lengths of the anode layer strips.

Electronic elements called pixels are formed at the cross points (where an anode layer strip intersects a cathode layer strip when the array is seen from a plan or top view).

In other embodiments, additional layer (s) may be present within organic electronic devices. For example, a layer (not shown) between the hole injecting layer (b) and the active layer (c) may facilitate positive charge transport, band-gap matching of the layers, function as a protective layer, or the like. Similarly, additional layers (not shown) between the electron injecting layer (d) and the cathode layer (e) may facilitate negative charge transport, band-gap matching between the layers, function as a protective layer, or the like. Layers that are known in the art can be used. Some or all of the layers may be surface treated to increase charge carrier transport efficiency. The choice of materials for each of the component layers may be determined by balancing the goals of providing a device with high device efficiency with the cost of manufacturing, manufacturing complexities, or potentially other factors.

The charge transport layers (b) and (d) are generally of the same type as the active layer (c). More specifically, if the active layer (c) has a small molecule compound, then the charge transport layers (b) and (d), if either or both are present, can have a different small molecule compound. If the active layer (c) has a polymer, the charge transport layers (b) and (d), if either or both are present, can also have a different polymer. Still, the active layer (c) may be a small molecule compound, and any of its adjacent charge transport layers may be polymers.

Each functional layer may be made up of more than one layer. For example, the cathode layer may comprise a layer of a Group 1 metal and a layer of aluminum. The Group 1 metal may lie closer to the active layer (c), and the aluminum may help to protect the Group 1 metal from environmental contaminants, such as water.

Although not meant to limit, the different layers may have the following range of thicknesses: inorganic anode layer (a), usually no greater than approximately 500 nm, for example, approximately 50-200 nm; optional hole-injecting layer (b), usually no greater than approximately 100 nm, for example, approximately 50-200 nm; active layer (c), usually no greater than approximately 100 nm, for example, approximately 10-80 nm; optional electron-injecting layer (d), usually no greater than approximately 100 nm, for example, approximately 10-80 nm; and cathode layer (e), usually no greater than approximately 1000 nm, for example, approximately 30-500 nm. If the anode layer (a) or the cathode layer (e) needs to transmit at least some light, the thickness of such layer may not exceed approximately 100 nm.

The location of the electron-hole recombination zone in the device, and thus the emission spectrum of the device, can be affected by the relative thickness of each layer. For example, when a potential light-emitting compound, such as Alq₃ is used in the electron transport layer (d), the electron-hole recombination zone can lie within the Alq₃ layer.

The emission would then be that of Alq₃, and not a desired sharp emission. Thus, the thickness of the electron-transport layer should be chosen so that the electron-hole recombination zone lies within the light-emitting layer (i.e., active layer (c)). The desired ratio of layer thicknesses can depend on the exact nature of the materials used.

The efficiency of the devices made with metal complexes can be further improved by optimizing the other layers in the device. For example, more efficient cathodes such as Ca, Ba, Mg/Ag, or LiF/AI can be used. Shaped substrates and hole transport materials that result in a reduction in operating voltage or increase quantum efficiency are also applicable. Additional layers can also be added to tailor the energy levels of the various layers and facilitate electroluminescence.

Depending upon the application of the electronic device, the active layer (c) can be a light-emitting layer that is activated by a signal (such as in a light-emitting diode) or a layer of material that responds to radiant energy and generates a signal with or without an applied potential (such as detectors or voltaic cells). Examples of electronic devices that may respond to radiant energy are selected from photoconductive cells, photoresistors, photoswitches, phototransistors, and phototubes, and photovoltaic cells. After reading this specification, skilled artisans will be capable of selecting material (s) that for their particular applications.

In OLEDs, electrons and holes, injected from the cathode (e) and anode (a) layers, respectively, into the photoactive layer (c), form negative and positively charged polarons in the active layer (c). These polarons migrate under the influence of the applied electric field, forming a polaron exciton with an oppositely charged species and subsequently undergoing radiative recombination. A sufficient potential difference between the anode and cathode, usually less than approximately 20 volts, and in some instances no greater than approximately 5 volts, may be applied to the device. The actual potential difference may depend on the use of the device in a larger electronic component. In many embodiments, the anode layer (a) is biased to a positive voltage and the cathode layer (e) is at substantially ground potential or zero volts during the operation of the electronic device. A battery or other power source (s) may be electrically connected to the electronic device as part of a circuit.

In other embodiments, the phosphorus-containing metal complex compound can be used as a charge transport material in layer (b) or (d).

The compound does not need to be in a solid matrix diluent (e.g., host charge transport material) when used in layer (b) (c), or (d) in order to be effective. A layer greater than approximately 1% by weight of the metal complex compound, based on the total weight of the layer, and up to substantially 100% of the complex compound can be used as the active layer (c). Additional materials can be present in the active layer (c) with the complex compound. For example, a fluorescent dye may be present to alter the color of emission.

A diluent may also be added. The diluent can be a polymeric material, such as poly (N-vinyl carbazole) and polysilane. It can also be a small molecule, such as 4,4′-N,N′-dicarbazole biphenyl or tertiary aromatic amines. When a diluent is used, the complex compound is generally present in a small amount, usually less than 20% by weight, preferably less than 10% by weight, based on the total weight of the layer.

The metallic complexes may be used in applications other than electronic devices. For example, the complexes may be used as catalysts or indicators (e.g., oxygen-sensitive indicators, phosphorescent indicators in bioassays, or the like).

The following examples illustrate certain features and advantages of the present invention. They are intended to be illustrative of the invention, but not limiting. All percentages are by weight, unless otherwise indicated.

EXAMPLES Example 1

a) An orange suspension of 82.6 g (0.6 mol) of 2-nitroaniline and 600 ml of water is treated at room temperature under nitrogen with 153.6 g (1.56 mol) of 37%-hydrochlorid acid with simultaneous cooling to 0° C. A solution of 45.6 g (0.66 mol) of sodium nitrite in 240 ml of water is added to the orange suspension over 75 min at 0° C., and then further reacted for 3 h at the same temperature, giving a yellow solution. A solution of 11.7 g (0.12 mol) of sulfamic acid in 120 ml of water is added dropwise over 1 h at 0° C. The resulting yellow solution is transferred into a dropping funnel and added over 30 min at room temperature to a light brown solution of 90.8 g (0.63 mol) of 2-naphthol in 2′500 ml of ethanol, giving an orange suspension. Stirring is continued at room temperature during 19 h. The suspension is filtered, washed two times with 500 ml of ethanol, suspended in 1,000 ml of water, filtered, and washed two times with 500 ml of water, and two times with 500 ml of ethanol. The resulting orange solid is further dried under vacuum giving the title product as an orange-red powder (yield: 163.4 g (93%)). Melting point: 214.3-215.6° C.

b) 88.0 g (0.3 mol) of the product of example 1a, 3.4 g (15 mmol) of 2,3-dichloro-1,4-naphthoquinone and 42 g (1.05 mol) of sodium hydroxide are dissolved under nitrogen in 170 ml of 2-butanol. The reddish black solution is heated up to reflux, and 100 ml of liquid are distilled off during 90 min. The reaction mixture is stirred for another 10 min at 96° C. 200 ml of 10%-aqueous hydrochloric acid are added first, followed by 300 ml of water. The organic phase is separated and 200 ml of ethyl acetate are added, and then washed with water (2×100 ml). Concentration of the organic phase leads to a dark solid which is dissolved in 400 ml of hot methanol. 500 ml of water are slowly added and the mixture stirred at room temperature during 30 min. The solid is filtered off and washed with 100 ml of water/methanol 1:1, dried under vacuum, giving the title product as a light grey powder (yield: 69.3 g (88.5%)). Melting point: 144.3-145.6° C.

c) 39.2 g (0.15 mol) of the product of example 1b are dissolved under nitrogen in 300 ml of dichloromethane, and treated with 29.7 g (0.375 mol) of pyridine. 50.8 g (0.18 mol) of trifluoromethanesulfonic anhydride are slowly added during 15 min under cooling, and stirring continued for 30 min at room temperature. 100 ml of water are added, the organic phase separated and washed with 5%-aqueous hydrochloric acid. The organic phase is washed with water, followed by filtration over silica gel. The filtrate is concentrated and recrystallized from isopropanol/water 9:1. The resulting solid is filtered off, dried under vacuum, giving the title product as a light pink solid (yield: 49.1 g (83%)). Melting point: 147.0-148.3° C.

d) 130 g (0.33 mol) of the product of example 1c are dissolved under argon in 500 ml of N,N-dimethylformamide (DMF). The solution is treated with 1.5 g (6.6 mmol) of palladium(II) acetate, 3.5 g (13.2 mmol) of triphenylphosphine, and 100.2 g (0.99 mol) of triethylamine. 30.4 g (0.66 mol) of formic acid are added at 20° C. and the mixture slowly heated up to 85° C. during 30 min. After heating for another 30 min at the same temperature, the black reaction mixture is cooled down to room temperature and treated with 2,000 ml of ethyl acetate and 2,000 ml of water. 1,500 ml of toluene are added and the resulting mixture filtered over silica gel. The organic phase is separated and washed two times with 1,000 ml of water, dried over sodium sulfate, and concentrated under vacuum. The grey solid is dissolved in 1500 ml of hot tert-butylmethylether, filtered and cooled down over an ice-bath. The solid is filtered off, washed with cold tert-butylmethylether and dried under vacuum, giving the title product as a light beige solid (yield: 47.3 g (59%)). Melting point: 143.5-144.3° C.

Example 2

a) The title compound is prepared according to the procedure of example 1a, with 207.2 g (1.5 mol) of 2-nitroaniline, 227 g (1.58 mol) of 1-naphthol, 113.9 g (1.65 mol) of sodium nitrite, and 29.1 g (0.3 mol) of sulfamic acid, providing the title product as an orange solid (yield: 432.4 g (98%). Melting point: 248.2-249.5° C.

b) 88 g (0.3 mol) of the product of example 2a and 55.2 g (1.38 mol) of sodium hydroxide are suspended at room temperature under nitrogen in 300 ml of ethanol and 600 ml of water and slowly heated up to 85° C. 90.8 g (0.84 mol) of formamidinesulfinic acid are suspended in water, and treated over an ice-bath with 33.6 g (0.84 mol) of sodium hydroxide, giving a colorless solution. The ice-cold, freshly prepared solution is added over 6 min to the preheated reaction mixture at 85° C., giving a yellow brown solution after complete addition. After 20 min heating the light beige solution is cooled down to room temperature and treated with 150 ml of 32%-hydrochloric acid. The resulting beige suspension is filtered, the solid dried under vacuum, followed by stirring in 2′500 ml of hexane. Filtration and drying gives the title product as a light beige powder (yield: 58.6 g (75%)). Melting point: 205.6-208.8° C.

c) 104.5 g (0.4 mol) of the product of example 2b is suspended at room temperature under nitrogen together with 52.8 g (0.8 mol) of powdered potassium hydroxide (purum, 85%) in 1,000 ml of N,N-dimethylformamide. 62.5 g (0.44 mol) of iodomethane are slowly added over 30 min. Stirring is continued for 25 min and the dark suspension poured into 2,000 ml under vigorous stirring. After 5 min, the resulting beige suspension is filtered, the solid washed with water (2×1,000 ml), suspended again in water, filtered, and washed with 500 ml water. Drying under vacuum gives the title product as light beige solid (yield: 106 g (96%)). Melting point: 131.5-133.0° C.

Example 3

The title product is prepared according to the procedure of example 2c, with 5.22 g (0.02 mol) of the product of example 2b, 2.64 g (0.04 mol) of potassium hydroxide (purum, 85%), 50 ml of N,N-dimethylformamide, and 3.43 g (0.022 mol) of iodoethane. After suspending the crude product several times in water, and filtration, the beige solid is dissolved in 50 ml of isopropanol. Addition of 50 ml of hexane, cooling, filtration and drying gives the title product as a grey powder (yield: 5.6 g (97%)). Melting point: 124-125.3° C.

Example 4

To 4.64 g (82.7 mmol) of potassium hydroxide (powder) in 65 ml of dimethylsulfoxide are added under nitrogen 5.40 g (20.7 mmol) of the product of example 2b. After 15 min 4.18 g (22.7 mmol) of 1-iodobutane are added. The reaction mixture is stirred for 3 h at room temperature. Water is added and the reaction mixture is extracted with diethyl ether. The organic phase is dried with magnesium sulphate and the solvent is removed. The product is filtered over silica gel with dichloromethane/hexane 2:1. Yield: 5.17 g.

Example 5

The title product is prepared according to the procedure of example 2c, with 39.2 g (0.15 mol) of the product of example 2b, 19.8 g (0.3 mol) of powdered potassium hydroxide (purum, 85%), 200 ml of N,N-dimethylformamide, and 28.1 g (0.165 mol) of 2-iodopropane. The reaction mixture is additionally heated during 2 h at 50° C. The resulting suspension is poured under strong stirring onto 500 ml of water, and after 5 min stirring extracted with ethyl acetate. The organic phase is washed three times with water, passed through a path of silica gel, and the silica gel rinsed with additional ethyl acetate. The eluent is concentrated under vacuum and the resulting solid recrystallized from hexane, giving the title product as a white solid (yield: 40.2 g (88%)). Melting point: 84.9-85.8° C.

Example 6

The title product is prepared according to the procedure of example 2c, with 5.2 g (0.02 mol) of the product of example 2b, 2.6 g (0.04 mol) of powdered potassium hydroxide (purum, 85%), 50 ml of N,N-dimethylformamide, and 4.1 g (0.022 mol) of 1-iodo-2-methylpropane. The resulting suspension is poured under strong stirring onto 300 ml of water, then treated with 32%-hydrochloric acid until a neutral pH is reached. The suspension is treated with ethyl acetate, and the organic phase washed three times with water. The organic phase is concentrated and the resulting solid dissolved in 100 ml of hot toluene. The solution is stirred at room temperature over night and the resulting solid filtered off, washed with cold hexane giving the title product as a solid (yield: 4.3 g (67%)). Melting point: 119-119.9° C.

Example 7

a) A yellow suspension of 103 g (0.5 mol) of 4-amino-3-nitrobenzotrifluoride is heated under nitrogen together with 900 ml of 85%-ortho-phosphoric acid to 50° C. and kept at this temperature for 75 min, and then cooled down to 0° C. A solution of 34.5 g (0.5 mol) of sodium nitrite in 80 ml of water is added over 25 min and stirred at 0° C. for 20 min. The resulting ice-cooled yellow suspension is transferred into a dropping funnel and slowly added under nitrogen to an ice-cooled yellow suspension of 75.7 g (0.525 mol) of 2-naphthol in 2′500 ml of methanol over 25 min. The orange suspension is filtered at room temperature and washed with methanol (3×500 ml), and suspended/filtered with water (4×1,000 ml). The remaining solid is dried under vacuum giving the title product as an orange powder (yield: 109 g (60%)). Melting point: 249.2-250.4° C.

b) The title product is prepared according to the procedure of example 1b, with 36.1 g (0.1 mol) of the product of example 7a, 1.13 g (0.005 mol) of 2,3-dichloro-1,4-naphthoquinone, 16.0 g (0.4 mol) of sodium hydroxide in 750 ml 2-butanol. After addition of hydrochloric acid and water, the organic phase is separated, and washed with water (2×250 ml). The organic phase is concentrated and the resulting solid dissolved in 50 ml of ethyl acetate. 300 ml of hexane are added giving a fine suspension. The suspension is filtered over silica gel and the silica gel rinsed with additional hexane. The combined eluents are concentrated and dried under vacuum giving the title product as a solid (yield: 18.7 g (57%)). Melting point: 118.5-119.3° C.

c) The title product is prepared according to the procedure of example 1c, with 58 g (0.176 mol) of the product of example 7b, 300 ml of dichloromethane, 34.8 g (0.44 mol) of pyridine and 59.5 g (0.211 mol) of trifluoromethanesulfonic anhydride. The reaction mixture is treated with 200 ml of water and diluted with 200 ml of dichloromethane. The organic phase is separated and washed with 100 ml of 5%-aqueous hydrochloric acid and water (2×150 ml), followed by filtration through silica gel. The filtrate is concentrated and dried under vacuum, giving the title compound as a brown solid (yield: 81 g (quant.)).

d) The title product is prepared according to the procedure of example 1d, with 78 g (0.169 mol) of the product of example 7c, 300 ml of isobutyl methyl ketone (IBMK) instead of N,N-dimethylformamide, 0.76 g (3.38 mmol) of palladium(II) acetate, 1.77 g (6.76 mmol) of triphenylphosphine, 51.3 g (0.507 mol) of triethylamine, and 15.6 g (0.338 mol) of formic acid. 10 g of activated charcoal are added after reaction and the mixture filtered, then diluted with 200 ml of ethyl acetate, and washed with water (3×200 ml). The organic phase is concentrated under vacuum giving a dark solid. The solid is dissolved in hot hexane, and heated during 15 min under reflux with 15 g of silica gel. The mixture is filtered and the filtrate cooled down to 0° C. After 1 h stirring at 0° C. the solid is filtered off and dried under vacuum, giving the title product as a light beige solid (yield: 28.6 g (54%)). Melting point: 106-107° C.

Example 8

a) The title product is prepared according to the procedure of example 1a, with 42.0 g (0.2 mol) of 4-amino-3-nitrobenzotrifluoride in 200 ml of methanol and 51.2 g (0.52 mol) of 37%-hydrochlorid acid, with 15.2 g (0.22 mol) of sodium nitrite in 60 ml of water, with 1.9 g (0.02 mol) of sulfamic acid, and 30.3 g (0.21 mol) of 1-naphthol in 200 ml of ethanol. The crude reaction product is filtered and washed with a small amount of ethanol, then suspended with water (3×400 ml), filtered and the solid dried under vacuum, giving the title product as an orange powder (yield: 32.5 g (45%)). Melting point: 230-230.5° C.

b) The title product is prepared according to the procedure of example 2b, with 18.0 g (0.05 mol) of the product of example 8a, 24.8 g (0.375 mol) of potassium hydroxide (85% content), 100 ml of ethanol, 150 ml of water, and 15.1 g (0.14 mol) of formamidinesulfinic acid. The crude reaction product is slightly acidified with diluted aqueous hydrochloric acid, and then put to a basic pH with aqueous sodium bicarbonate solution. The brownish product is extracted with ethyl acetate and the light brown organic phase concentrated under vacuum. The black solid is dissolved in dichloromethane and further purified by filtration over silica gel. The eluent is concentrated under vacuum giving the title product as a beige powder (yield: 9.2 g (56%)).

c) The title product is prepared according to the procedure of example 2c, with 8.2 g (0.025 mol) of the product of example 8b, 3.3 g (0.05 mol) of potassium hydroxide (85% content), 250 ml of N,N-dimethylformamide, and 3.9 g (27.5 mmol) of iodomethane. The crude reaction product is poured onto 200 ml of water, followed by extraction with ethyl acetate and washing with water. The organic phase is concentrated under vacuum. The resulting solid is dissolved in 20 ml of hot ethyl acetate, treated with 150 ml of hexane and 10 g of silica gel, and stirred during 15 min. Filtration and concentration gives the title product as a light brown powder (yield: 3.7 g (43%)). Melting point: 98.3-99.4° C.

Example 9

b) The title product is prepared according to the procedure of example 1b, with 61.4 g (0.2 mol) of Hansa-Scharlach RNC® (CAS 2425-85-6), 2.2 g (0.01 mol) of 2,3-dichloro-1,4-naphthoquinone, 28.0 g (0.7 mol) of sodium hydroxide in 1,000 ml of 2-butanol. After 150 min at 96° C. the reaction mixture is treated with 16.3 g (0.25 mol) of zinc and stirring continued for 90 min at 97° C. The hot reaction mixture is filtered, cooled down and acidified with diluted hydrochloric acid. The mixture is extracted with 1,000 ml of ethyl acetate and the organic phase washed with water (4×500 ml). The organic phase is concentrated under vacuum and the resulting solid further dried under vacuum at 70° C., giving the title product as dark colored solid (yield: 34.8 g (63%)). Melting point: 132.5-133.3° C.

c) The title product is prepared according to the procedure of example 1c, with 33.9 g (0.123 mol) of the product of example 9b in 300 ml of dichloromethane, with 24.3 g (307.5 mmol) of pyridine and 41.6 g (147.6 mmol) of trifluoromethanesulfonic anhydride. The crude reaction mixture is poured onto 500 ml of water. The organic phase is separated, washed with water (2×300 ml), and concentrated under vacuum The title product is obtained as a dark solid (50 g (quant.)).

d) The title product is prepared according to the procedure of example 1d, with 50 g (0.122 mol) of the product of example 9c in 300 ml of N,N-dimethylformamide (DMF), 0.55 g (2.44 mmol) of palladium(II) acetate, 1.28 g (4.88 mmol) of triphenyl phosphine, 37 g (0.366 mol) of triethylamine, and 11.2 g (0.244 mol) of formic acid. The crude reaction product is cooled down, extracted with hexane (4×500 ml), the organic phase filtered over silica gel, and concentrated under vacuum, giving the title product as a beige powder (yield: 8.4 g (27%)). Melting point: 133.2-133.9° C.

Example 10

a) The title compound is prepared according to the procedure of example 7a, with 10.0 g (72.4 mmol) of 2-nitroaniline, 100 ml of 85%-ortho-phosphoric acid, with 5.00 g (72.4 mmol)) of sodium nitrite in water, and 13.0 g (76.0 mmol) of N,N-dimethyl-1-naphthylamine in 100 ml of methanol. The crude reaction mixture is poured into 300 ml of water, extracted with dichloromethane, dried, and concentrated under vacuum. Purification is done via flash chromatography (SiO₂, dichloromethane/hexane 2:1) giving the title product as a viscous oil (yield: 15.0 g (65%)).

b) 17.47 g (0.687 mol) of sodium hydroxide are dissolved in 159 ml of water and treated with a solution of 11.0 g (34.3 mmol) of the product of example 10a in 159 ml of ethanol. The temperature is raised to 85° C. giving a clear solution. Stirring is stopped, the heating bath is removed, and 8.35 g (77.3 mmol) of formamidinesulfinic acid are added in two portions over 30 s. Stirring is slowly started again and the reaction mixture poured into ice-water after 1 h reaction time. The mixture is extracted with dichloromethane and the organic phase washed with water. The organic phase is concentrated under vacuum giving a slowly crystallizing product. Further purification is done via flash-chromatography over silica gel, giving the title compound as a solid (yield: 2.44 g (25%)).

Example 11 Alternative Method for the Preparation of Example 1

a) To 10.0 g (58.1 mmol) of 2-bromoaniline in 100 ml of ethanol are added 5.76 g (58.7 mmol) of sulphuric acid. The solvent is distilled off. The solid is dissolved in 150 ml water and 5.3 ml 32% HCl. The reaction mixture is cooled to 0° C. and an ice-cold solution of 4.01 g (58.1 mmol) of sodium nitrite in 25 ml water is slowly added. The reaction mixture is stirred at 0° C. for 2 h and added slowly to an ice-cold solution of 8.38 g (58.1 mmol) of 2-naphthol in 300 ml of ethanol. After 2 h stirring at room temperature 500 ml of dichloromethane and 200 ml of water are added and the water phase is separated. The organic phase is washed two times with water, dried with sodium sulphate, and concentrated under vacuum, giving the title product (yield: 18.3 g (94%)).

b) 1.00 g (2.97 mmol) of the product of example 11a, 0.19 g (2.97 mmol) of sodium azide and 5 mg of copper(I) bromide are suspended under nitrogen in 10 ml of N,N-dimethyl-formamide (DMF). The reaction mixture is stirred for 8 h at 80° C. Additional 0.19 g of sodium azide are added and the reaction mixture is heated for 2 h at 80° C. Water is added and the reaction mixture is extracted with dichloromethane. The organic phase is extracted with a 10%-sodium hydroxide solution. The water phase is acidified with 32%-hydrochloric acid and extracted with dichloromethane. The organic phase is washed with water, dried with magnesium sulphate, filtered, and concentrated under vacuum, giving the title product (yield: 530 mg (68%)). Reference is made to Journal of Organic Chemistry 1968, 33, 7, 2954.

c) To 5.00 g (19.1 mmol) of the product of example 11b in 60 ml of dichloromethane and 3.78 g (47.4 mmol) of pyridine, 6.48 g (23.0 mmol) of trifluoromethanesulfonic anhydride are added dropwise under nitrogen. The reaction mixture is stirred for 1 h at 25° C., washed with water, dried with magnesium sulphate, and concentrated under vacuum, giving the title product as a white solid (yield: 7.36 g (98%)).

d) 7.30 g (18.5 mmol) of the product of example 11c, 5.63 g (55.7 mmol) of triethylamine, 80 mg (0.37 mmol) of palladium(II) acetate, 190 mg (0.74 mmol) of triphenylphosphine are dissolved under nitrogen in 29 ml of N,N-dimethylformamide (DMF). The reaction mixture is degassed and 1.71 g (37.1 mmol) of formic acid are added dropwise. The reaction mixture is stirred at 80° C. for 150 min. Water is added and the water phase is extracted with ethyl acetate. The organic phase is dried with magnesium sulphate and the solvent is distilled off. The product is crystallized two times from methanol. Yield: 1.80 g (40%).

Example 12

40.0 g (0.163 mol) of the product of example 1d and 29.9 g (81.5 mmol) of iridium(III)-chloride hydrate (52.46% iridium-content) are suspended at room temperature under argon in a mixture of 1,000 ml of 2-ethoxyethanol and 300 ml of water. The reaction mixture is heated up to 110° C. and kept at this temperature for 22 h. The dark red suspension is cooled down to room temperature, filtered, washed with absolute ethanol, and dried under vacuum. The title product is obtained as a brownish red powder (yield: 55.5 g (95%)).

Example 13

16.5 g (0.06 mol) of the product of example 2c and 10.5 g (28.6 mmol) of iridium(III)chloride hydrate (52.42% iridium-content) are suspended at room temperature under nitrogen in a mixture of 300 ml of 2-ethoxyethanol and 100 ml of water. The grey-black reaction mixture is heated up to 110° C. and kept at this temperature for 21 h. The dark red suspension is cooled down to room temperature, filtered, washed with absolute ethanol, and dried under vacuum. The title product is obtained as a brownish red powder (yield: 19.74 g (89%)).

Example 14

Please note, a ligand

wherein R is, for example, CF₃, or CH₃, can coordinate in to different ways to iridium. The two possibilities

are represented by the following notation

throughout the examples to simplify matters.

21 g (67 mmol) of the product of example 7d and 11.6 g (31.9 mmol) of iridium(III)chloride hydrate (52.84% iridium-content) are suspended at room temperature under nitrogen in a mixture of 250 ml of 2-ethoxyethanol and 75 ml of water. The grey-black reaction mixture is heated up to 110° C. and kept at this temperature for 22 h. The dark red suspension is cooled down to room temperature, filtered, washed with absolute ethanol, and dried under vacuum. The title product is obtained as a red powder (yield: 22.3 g (82%)).

Examples 15-21

The following diiridium complexes are prepared according to the procedure reported for example 12, giving the products of examples 15-21. The respective m/z-values of the product structures have been detected by HPLC-MS measurements.

Example Ligand Diiridium complex 15  3d

16  4

17  5

18  6

19  8d

20  9d

21 10b

Example 22

To 2.00 g (1.40 mmol) of the product of example 12 are added under argon 980 mg (9.22 mmol) of sodium carbonate and 66 ml of 2-ethoxyethanol. The suspension is evacuated and put under argon three times. 360 mg (360 mmol) of acetyl acetone are added. The reaction mixture is refluxed under argon for 18 h. The product is filtered off, dissolved in dichloromethane and filtered over silica gel. The solvent is removed and 50 ml of ethoxyethanol are added. The suspension is refluxed for 1 h. The product is filtered off and dried under vacuum, giving the title product as orange-red powder (yield: 1.56 g (72%)).

Example 23

25 g (16.1 mmol) of the product of example 13 and 11.3 g (106 mmol) of sodium carbonate are suspended under argon in 500 ml of 2-ethoxyethanol. The suspension is evacuated and put under argon three times. 4.2 g (41.9 mmol) of acetylacetone are added and the orange suspension heated up to 100° C. and kept at this temperature for 1 h. The reaction mixture is cooled down to room temperature and washed with 200 ml of ethanol, suspended several times with water and washed extensively with ethanol. The resulting solid is dried under vacuum giving the title compound as an red powder (yield: 23.5 g (87%)).

Example 24

18 g (10.6 mmol) of the product of example 14 and 7.4 g (0.07 mol) of sodium carbonate are suspended under argon in 100 ml of 2-ethoxyethanol. The suspension is evacuated and put under argon three times. 5.5 g (55 mmol) of acetylacetone are added and the orange suspension heated up to 100° C., and kept at this temperature for 45 min. 0.5 g of acetyl acetone are added, and heating continued for 30 min. The reaction mixture is cooled down to room temperature and washed with 200 ml of ethanol, suspended several times in water and washed with ethanol. The resulting solid is dried under vacuum giving the title compound as a red powder (yield: 18.5 g (96%)).

Examples 22-96

The iridium complexes are prepared according to Example 24, with the respective ancillary ligands given in the table below, instead of acetyl acetone, starting from the products of examples 12-21. In the case of the iridium complexes of examples 35, 45, and 87, preparation has been done according to the procedure of Example 12 in WO2006/000544, from the respective diiridium complexes as starting material (products from examples 12-21), with silver trifluoromethane sulfonate in acetone or 2-nonanone, and the respective ancillary ligand given in the table below. The respective m/z-values of the product structures have been detected by HPLC-MS measurements. All photoluminescence (PL) spectra were measured with a Perkin Elmer Luminance Spectrometer LS 50 B. Materials were dissolved in toluene, and the solution purged with nitrogen in a sealed cuvette. Excitation of the solutions was done at various wavelengths dependent on the absorption characteristics which were measured before PL measurement was carried out using the same cuvettes and solutions. The spectrometer is equipped with two different lamps and covers a wavelength range from 250-800 nm. Colour coordinates CIE x,y were determined from PL spectra and calculated by a software provided with the spectrometer.

Ex. Compound HL Iridium complex CIE x, y 22

0.62, 0.37 23

0.63, 0.36 24

0.66, 0.33 25

0.62, 0.37 26

0.63, 0.37 27

0.62, 0.37 28

0.62, 0.37 29

0.62, 0.37 30

0.60, 0.39 31

0.59, 0.40 32

0.61, 0.38 33

0.62, 0.37 34

0.60, 0.39 35

0.57, 0.42 36

0.60, 0.39 37

0.61, 0.38 38

0.61, 0.38 39

0.61, 0.38 40

0.62, 0.38 41

0.62, 0.37 42

0.62, 0.37 43

0.61, 0.39 44

0.63, 0.36 45

0.59, 0.40 46

0.63, 0.36 47

0.64, 0.35 48

0.62, 0.37 49

0.62, 0.37 50

0.62, 0.36 51

0.62, 0.37 52

0.63, 0.36 53

0.63, 0.37 54

0.62, 0.37 55

0.62, 0.37 56

0.62, 0.37 57

0.62, 0.37 58

0.63, 0.37 59

0.64, 0.36 60

0.64, 0.36 61

0.63, 0.37 62

0.60, 0.40 63

0.62, 0.38 64

0.63, 0.37 65

0.62, 0.38 66

0.64, 0.36 67

0.62, 0.37 68

0.62, 0.37 69

0.63, 0.37 70

0.65, 0.35 71

0.65, 0.35 72

0.63, 0.37 73

0.64, 0.36 74

0.64, 0.36 75

0.65, 0.35 76

0.65, 0.35 77

78

0.66, 0.34 79

0.64, 0.36 80

0.64, 0.36 81

0.64, 0.36 82

0.65, 0.35 83

0.64, 0.36 84

0.66, 0.34 85

0.66, 0.34 86

0.66, 0.34 87

0.62, 0.38 88

0.64, 0.36 89

0.66, 0.34 90

0.68, 0.32 91

0.65, 0.34 92

0.68, 0.32 93

0.68, 0.32 94

0.66, 0.34 95

0.67, 0.33 96

0.67, 0.33

Application Example 1

Product of example 22 of the present invention:

PL (max.) CIE (X, Y) Color 601 nm 0.62, 0.37 red

Comparative Application Example 1

Iridium complex of Example 6 in WO2006/000544

PL (max.) CIE (X, Y) Color 557 nm 0.44, 0.51 yellow

As evident from Comparative Application Example 1 the product of Example 6 in WO2006/000544 does not show the desired red luminescence.

Application Example 2

Device fabrication: Prior to device fabrication, indium tin oxide (ITO) on glass is patterned as 2 mm wide stripes (sheet resistance 20 Ω/square). The substrates are cleaned by sonication in a alkaline solution (Deconex), rinsing with deionized water, exposed to acetone and isopropanol for 3-4 min in each solvent. After the cleaning procedure, the substrates are dried under a nitrogen flow followed by UV ozone treatment for 10 min.

Organic layers of the OLEDs are sequentially deposited by thermal evaporation from resistively heated tantalum boats at a base pressure of 2×10⁻⁶ Torr, at 2 A/s.

The rate of each single component source is controlled by a thickness monitor (Inficon) close to the substrate. All the devices are encapsulated with a glass lid sealed with an epoxy resin in a nitrogen glove box, immediately after fabrication.

The devices are characterized in air. Current-voltage measurements are made with a Keithley source meter (model 2400). Light intensity is measured using a Newport model 1835 optical power meter and a Newport detector. EL specta were measured with a Photon Technology International fluorimeter.

An OLED is prepared having the following structure from the anode to the cathode: 10 nm of copper phtalocyanine (CuPc), using 10 nm of an improved hole transport layer, such as NHT5:NDP2 of Novaled AG, 10 nm of 4,4′ bis[N-81-naphthyl)-N-phenylamino]-biphenyl (α-NPD), 20 nm of aluminum(III) bis(2-methyl-8-quinolato) 4-phenyl-phenolate (BAlq) doped with 15 wt % of compound B-2 obtained in example 23, 10 nm of BAlq acting as hole blocking layer, 60 nm of an improved electron transport layer, such as NET-5:NDN-1 from Novaled, and 130 nm of aluminium as top electrode.

Comparative Application Example 2

The element is prepared and evaluated in the same manner as described in Application Example 2, except for using complex A instead of Cpd. B-2. The synthesis of complex A is described in Example 12 of WO2006/000544, with 2-nonanone as solvent instead of acetone, using 1-(3-methoxy-phenyl)-isoquinoline instead of phenylpyridine, and using a reaction temperature of 150-180° C. in the second reaction step.

The organic stack consists of ITO/10 nm of CuPc/10 nm of NHT5:NDP2/10 nm of α-NPD/20 nm of BAlq doped with 15 wt % complex A/10 nm BAlq/60 nm NET-5:NDN-1/130 nm Al.

The power efficiency of the device of Application Example 2 is more than doubled than that of the device of the Comparative Application Example (see the following table):

Current eff. Power eff. Voltage EML cd/A @ 1000 cd/m² lm/W @1000 cd/m² V @ 1000 cd/m² CIE X CIE Y Application BAlq: 15 wt % 8.8 8.2 3.39 0.66 0.34 Example 2 dopant¹⁾ Comparative BAlq: 15 wt % 4.7 3.5 4.19 0.67 0.32 Application dopant²⁾ Example 2 ¹⁾Compound B-2. ²⁾Complex A.

While WO2006/000544 also describes red emitting compounds (Complex A), those compounds are less efficient as corresponding compounds of the present invention (compound B-2). 

The invention claimed is:
 1. A compound of formulae shown below:

wherein Cpd. R² R³ R⁶ A-2 H H OCH₃ A-3 H H OCH₂CH₃ A-4 H H O-n-butyl A-5 H H O-iso-butyl A-6 H H O-2-butyl A-7 H H O-2-ethylhexyl A-8 H H N(CH₃)₂ A-9 H H NPh₂ A-10 H CF₃ H A-11 CF₃ H H A-12 H CF₃ OCH₃ A-13 CF₃ H OCH₃ A-14 H CF₃ OCH₂CH₃ A-15 CF₃ H OCH₂CH₃ A-16 H CF₃ O-n-butyl A-17 CF₃ H O-n-butyl A-18 H CF₃ O-iso-butyl A-19 CF₃ H O-iso-butyl A-20 H CF₃ O-2-butyl A-21 CF₃ H O-2-butyl A-22 H CF₃ O-2-ethylhexyl A-23 CF₃ H O-2-ethylhexyl A-24 H CF₃ N(CH₃)₂ A-25 CF₃ H N(CH₃)₂ A-26 H CF₃ NPh₂ A-27 CF₃ H NPh₂ A-28 H CN H A-29 CN H H A-30 H CN OCH₃ A-31 CN H OCH₂CH₃ A-32 H CN OCH₂CH₃ A-33 CN H O-n-butyl A-34 H CN O-n-butyl A-35 CN H O-iso-butyl A-36 H CN O-iso-butyl A-37 CN H O-2-butyl A-38 H CN O-2-butyl A-39 CN H O-2-ethylhexyl A-40 H CN O-2-ethylhexyl A-41 CN H N(CH₃)₂ A-42 H CN N(CH₃)₂ A-43 CN H NPh₂ A-44 H CN NPh₂

wherein Cpd. L′ R² R³ R⁶ B-1 A¹⁾ H H H B-2 A¹⁾ H H OCH₃ B-3 A¹⁾ H H OCH₂CH₃ B-4 A¹⁾ H H O-n-butyl B-5 A¹⁾ H H O-iso-butyl B-6 A¹⁾ H H O-2-butyl B-7 A¹⁾ H H O-2-ethylhexyl B-8 A¹⁾ H H N(CH₃)₂ B-9 A¹⁾ H H NPh₂ B-10 A¹⁾ H CF₃ H B-11 A¹⁾ CF₃ H H B-12 A¹⁾ H CF₃ OCH₃ B-13 A¹⁾ CF₃ H OCH₃ B-14 A¹⁾ H CF₃ OCH₂CH₃ B-15 A¹⁾ CF₃ H OCH₂CH₃ B-16 A¹⁾ H CF₃ O-n-butyl B-17 A¹⁾ CF₃ H O-n-butyl B-18 A¹⁾ H CF₃ O-iso-butyl B-19 A¹⁾ CF₃ H O-iso-butyl B-20 A¹⁾ H CF₃ O-2-butyl B-21 A¹⁾ CF₃ H O-2-butyl B-22 A¹⁾ H CF₃ O-2-ethylhexyl B-23 A¹⁾ CF₃ H O-2-ethylhexyl B-24 A¹⁾ H CF₃ N(CH₃)₂ B-25 A¹⁾ CF₃ H N(CH₃)₂ B-26 A¹⁾ H CF₃ NPh₂ B-27 A¹⁾ CF₃ H NPh₂ B-28 A¹⁾ H CN H B-29 A¹⁾ CN H H B-30 A¹⁾ CN H OCH₃ B-31 A¹⁾ H CN OCH₃ B-32 A¹⁾ CN H OCH₂CH₃ B-33 A¹⁾ H CN OCH₂CH₃ B-34 A¹⁾ CN H O-n-butyl B-35 A¹⁾ H CN O-n-butyl B-36 A¹⁾ CN H O-iso-butyl B-37 A¹⁾ H CN O-iso-butyl B-38 A¹⁾ CN H O-2-butyl B-39 A¹⁾ H CN O-2-butyl B-40 A¹⁾ CN H O-2-ethylhexyl B-41 A¹⁾ H CN O-2-ethylhexyl B-42 A¹⁾ CN H N(CH₃)₂ B-43 A¹⁾ H CN N(CH₃)₂ B-44 A¹⁾ CN H NPh₂ B-45 A¹⁾ H CN NPh₂ B-46 B¹⁾ H H H B-47 B¹⁾ H H OCH₃ B-48 B¹⁾ H H OCH₂CH₃ B-49 B¹⁾ H H O-n-butyl B-50 B¹⁾ H H O-iso-butyl B-51 B¹⁾ H H O-2-butyl B-52 B¹⁾ H H O-2-ethylhexyl B-53 B¹⁾ H H N(CH₃)₂ B-54 B¹⁾ H H NPh₂ B-55 B¹⁾ H CF₃ H B-56 B¹⁾ CF₃ H H B-57 B¹⁾ H CF₃ OCH₃ B-58 B¹⁾ CF₃ H OCH₃ B-59 B¹⁾ H CF₃ OCH₂CH₃ B-60 B¹⁾ CF₃ H OCH₂CH₃ B-61 B¹⁾ H CF₃ O-n-butyl B-62 B¹⁾ CF₃ H O-n-butyl B-63 B¹⁾ H CF₃ O-iso-butyl B-64 B¹⁾ CF₃ H O-iso-butyl B-65 B¹⁾ H CF₃ O-2-butyl B-66 B¹⁾ CF₃ H O-2-butyl B-67 B¹⁾ H CF₃ O-2-ethylhexyl B-68 B¹⁾ CF₃ H O-2-ethylhexyl B-69 B¹⁾ H CF₃ N(CH₃)₂ B-70 B¹⁾ CF₃ H N(CH₃)₂ B-71 B¹⁾ H CF₃ NPh₂ B-72 B¹⁾ CF₃ H NPh₂ B-73 B¹⁾ H CN H B-74 B¹⁾ CN H H B-75 B¹⁾ CN H OCH₃ B-76 B¹⁾ H CN OCH₃ B-77 B¹⁾ CN H OCH₂CH₃ B-78 B¹⁾ H CN OCH₂CH₃ B-79 B¹⁾ CN H O-n-butyl B-80 B¹⁾ H CN O-n-butyl B-81 B¹⁾ CN H O-iso-butyl B-82 B¹⁾ H CN O-iso-butyl B-83 B¹⁾ CN H O-2-butyl B-84 B¹⁾ H CN O-2-butyl B-85 B¹⁾ CN H O-2-ethylhexyl B-86 B¹⁾ H CN O-2-ethylhexyl B-87 B¹⁾ CN H N(CH₃)₂ B-88 B¹⁾ H CN N(CH₃)₂ B-89 B¹⁾ CN H NPh₂ B-99 B¹⁾ H CN NPh₂ B-100 C¹⁾ H H H B-101 C¹⁾ H H OCH₃ B-102 C¹⁾ H H OCH₂CH₃ B-103 C¹⁾ H H O-n-butyl B-104 C¹⁾ H H O-iso-butyl B-105 C¹⁾ H H O-2-butyl B-106 C¹⁾ H H O-2-ethylhexyl B-107 C¹⁾ H H N(CH₃)₂ B-108 C¹⁾ H H NPh₂ B-109 C¹⁾ H CF₃ H B-110 C¹⁾ CF₃ H H B-111 C¹⁾ H CF₃ OCH₃ B-112 C¹⁾ CF₃ H OCH₃ B-113 C¹⁾ H CF₃ OCH₂CH₃ B-114 C¹⁾ CF₃ H OCH₂CH₃ B-115 C¹⁾ H CF₃ O-n-butyl B-116 C¹⁾ CF₃ H O-n-butyl B-117 C¹⁾ H CF₃ O-iso-butyl B-118 C¹⁾ CF₃ H O-iso-butyl B-119 C¹⁾ H CF₃ O-2-butyl B-120 C¹⁾ CF₃ H O-2-butyl B-121 C¹⁾ H CF₃ O-2-ethylhexyl B-122 C¹⁾ CF₃ H O-2-ethylhexyl B-123 C¹⁾ H CF₃ N(CH₃)₂ B-124 C¹⁾ CF₃ H N(CH₃)₂ B-125 C¹⁾ H CF₃ NPh₂ B-126 C¹⁾ CF₃ H NPh₂ B-127 C¹⁾ H CN H B-128 C¹⁾ CN H H B-129 C¹⁾ CN H OCH₃ B-130 C¹⁾ H CN OCH₃ B-131 C¹⁾ CN H OCH₂CH₃ B-132 C¹⁾ H CN OCH₂CH₃ B-133 C¹⁾ CN H O-n-butyl B-134 C¹⁾ H CN O-n-butyl B-135 C¹⁾ CN H O-iso-butyl B-136 C¹⁾ H CN O-iso-butyl B-137 C¹⁾ CN H O-2-butyl B-138 C¹⁾ H CN O-2-butyl B-139 C¹⁾ CN H O-2-ethylhexyl B-140 C¹⁾ H CN O-2-ethylhexyl B-141 C¹⁾ CN H N(CH₃)₂ B-142 C¹⁾ H CN N(CH₃)₂ B-143 C¹⁾ H CN NPh₂ B-144 C¹⁾ CN H NPh₂ B-145 D¹⁾ H H H B-146 D¹⁾ H H OCH₃ B-147 D¹⁾ H H OCH₂CH₃ B-148 D¹⁾ H H O-n-butyl B-149 D¹⁾ H H O-iso-butyl B-150 D¹⁾ H H O-2-butyl B-151 D¹⁾ H H O-2-ethylhexyl B-152 D¹⁾ H H N(CH₃)₂ B-153 D¹⁾ H H NPh₂ B-154 D¹⁾ H CF₃ H B-155 D¹⁾ CF₃ H H B-156 D¹⁾ H CF₃ OCH₃ B-157 D¹⁾ CF₃ H OCH₃ B-158 D¹⁾ H CF₃ OCH₂CH₃ B-159 D¹⁾ CF₃ H OCH₂CH₃ B-160 D¹⁾ H CF₃ O-n-butyl B-161 D¹⁾ CF₃ H O-n-butyl B-162 D¹⁾ H CF₃ O-iso-butyl B-163 D¹⁾ CF₃ H O-iso-butyl B-164 D¹⁾ H CF₃ O-2-butyl B-165 D¹⁾ CF₃ H O-2-butyl B-166 D¹⁾ H CF₃ O-2-ethylhexyl B-167 D¹⁾ CF₃ H O-2-ethylhexyl B-168 D¹⁾ H CF₃ N(CH₃)₂ B-169 D¹⁾ CF₃ H N(CH₃)₂ B-170 D¹⁾ H CF₃ NPh₂ B-171 D¹⁾ CF₃ H NPh₂ B-172 D¹⁾ H CN H B-173 D¹⁾ CN H H B-174 D¹⁾ CN H OCH₃ B-175 D¹⁾ H CN OCH₃ B-176 D¹⁾ CN H OCH₂CH₃ B-177 D¹⁾ H CN OCH₂CH₃ B-178 D¹⁾ CN H O-n-butyl B-179 D¹⁾ H CN O-n-butyl B-180 D¹⁾ CN H O-iso-butyl B-181 D¹⁾ H CN O-iso-butyl B-182 D¹⁾ CN H O-2-butyl B-183 D¹⁾ H CN O-2-butyl B-184 D¹⁾ CN H O-2-ethylhexyl B-185 D¹⁾ H CN O-2-ethylhexyl B-186 D¹⁾ CN H N(CH₃)₂ B-187 D¹⁾ H CN N(CH₃)₂ B-188 D¹⁾ CN H NPh₂ B-189 D¹⁾ H CN NPh₂ B-190 E¹⁾ H H H B-191 E¹⁾ H H OCH₃ B-192 E¹⁾ H H OCH₂CH₃ B-193 E¹⁾ H H O-n-butyl B-194 E¹⁾ H H O-iso-butyl B-195 E¹⁾ H H O-2-butyl B-196 E¹⁾ H H O-2-ethylhexyl B-197 E¹⁾ H H N(CH₃)₂ B-198 E¹⁾ H H NPh₂ B-199 E¹⁾ H CF₃ H B-200 E¹⁾ CF₃ H H B-201 E¹⁾ H CF₃ OCH₃ B-202 E¹⁾ CF₃ H OCH₃ B-203 E¹⁾ H CF₃ OCH₂CH₃ B-204 E¹⁾ CF₃ H OCH₂CH₃ B-205 E¹⁾ H CF₃ O-n-butyl B-206 E¹⁾ CF₃ H O-n-butyl B-207 E¹⁾ H CF₃ O-iso-butyl B-208 E¹⁾ CF₃ H O-iso-butyl B-209 E¹⁾ H CF₃ O-2-butyl B-210 E¹⁾ CF₃ H O-2-butyl B-211 E¹⁾ H CF₃ O-2-ethylhexyl B-212 E¹⁾ CF₃ H O-2-ethylhexyl B-213 E¹⁾ H CF₃ N(CH₃)₂ B-214 E¹⁾ CF₃ H N(CH₃)₂ B-215 E¹⁾ H CF₃ NPh₂ B-216 E¹⁾ CF₃ H NPh₂ B-217 E¹⁾ H CN H B-218 E¹⁾ CN H H B-219 E¹⁾ CN H OCH₃ B-220 E¹⁾ H CN OCH₃ B-221 E¹⁾ CN H OCH₂CH₃ B-222 E¹⁾ H CN OCH₂CH₃ B-223 E¹⁾ CN H O-n-butyl B-224 E¹⁾ H CN O-n-butyl B-225 E¹⁾ CN H O-iso-butyl B-226 E¹⁾ H CN O-iso-butyl B-227 E¹⁾ CN H O-2-butyl B-228 E¹⁾ H CN O-2-butyl B-229 E¹⁾ CN H O-2-ethylhexyl B-230 E¹⁾ H CN O-2-ethylhexyl B-231 E¹⁾ CN H N(CH₃)₂ B-232 E¹⁾ H CN N(CH₃)₂ B-233 E¹⁾ CN H NPh₂ B-234 E¹⁾ H CN NPh₂

wherein Cpd. R² R³ R⁶ C-1 H H H C-2 H H OCH₃ C-3 H H OCH₂CH₃ C-4 H H O-n-butyl C-5 H H O-iso-butyl C-6 H H O-2-butyl C-7 H H O-2-ethylhexyl C-8 H H N(CH₃)₂ C-9 H H NPh₂ C-10 H CF₃ H C-11 CF₃ H H C-12 H CF₃ OCH₃ C-13 CF₃ H OCH₃ C-14 H CF₃ OCH₂CH₃ C-15 CF₃ H OCH₂CH₃ C-16 H CF₃ O-n-butyl C-17 CF₃ H O-n-butyl C-18 H CF₃ O-iso-butyl C-19 CF₃ H O-iso-butyl C-20 H CF₃ O-2-butyl C-21 CF₃ H O-2-butyl C-22 H CF₃ O-2-ethylhexyl C-23 CF₃ H O-2-ethylhexyl C-24 H CF₃ N(CH₃)₂ C-25 CF₃ H N(CH₃)₂ C-26 H CF₃ NPh₂ C-27 CF₃ H NPh₂ C-28 H CN H C-29 CN H H C-30 H CN OCH₃ C-31 CN H OCH₂CH₃ C-32 H CN OCH₂CH₃ C-33 CN H O-n-butyl C-34 H CN O-n-butyl C-35 CN H O-iso-butyl C-36 H CN O-iso-butyl C-37 CN H O-2-butyl C-38 H CN O-2-butyl C-39 CN H O-2-ethylhexyl C-40 H CN O-2-ethylhexyl C-41 CN H N(CH₃)₂ C-42 H CN N(CH₃)₂ C-43 CN H NPh₂ C-44 H CN NPh₂

wherein Cpd. L′ R² R³ R⁶ D-1 A¹⁾ H H H D-2 A¹⁾ H H OCH₃ D-3 A¹⁾ H H OCH₂CH₃ D-4 A¹⁾ H H O-n-butyl D-5 A¹⁾ H H O-iso-butyl D-6 A¹⁾ H H O-2-butyl D-7 A¹⁾ H H O-2-ethylhexyl D-8 A¹⁾ H H N(CH₃)₂ D-9 A¹⁾ H H NPh₂ D-10 A¹⁾ H CF₃ H D-11 A¹⁾ CF₃ H H D-12 A¹⁾ H CF₃ OCH₃ D-13 A¹⁾ CF₃ H OCH₃ D-14 A¹⁾ H CF₃ OCH₂CH₃ D-15 A¹⁾ CF₃ H OCH₂CH₃ D-16 A¹⁾ H CF₃ O-n-butyl D-17 A¹⁾ CF₃ H O-n-butyl D-18 A¹⁾ H CF₃ O-iso-butyl D-19 A¹⁾ CF₃ H O-iso-butyl D-20 A¹⁾ H CF₃ O-2-butyl D-21 A¹⁾ CF₃ H O-2-butyl D-22 A¹⁾ H CF₃ O-2-ethylhexyl D-23 A¹⁾ CF₃ H O-2-ethylhexyl D-24 A¹⁾ H CF₃ N(CH₃)₂ D-25 A¹⁾ CF₃ H N(CH₃)₂ D-26 A¹⁾ H CF₃ NPh₂ D-27 A¹⁾ CF₃ H NPh₂ D-28 A¹⁾ H CN H D-29 A¹⁾ CN H H D-30 A¹⁾ CN H OCH₃ D-31 A¹⁾ H CN OCH₃ D-32 A¹⁾ CN H OCH₂CH₃ D-33 A¹⁾ H CN OCH₂CH₃ D-34 A¹⁾ CN H O-n-butyl D-35 A¹⁾ H CN O-n-butyl D-36 A¹⁾ CN H O-iso-butyl D-37 A¹⁾ H CN O-iso-butyl D-38 A¹⁾ CN H O-2-butyl D-39 A¹⁾ H CN O-2-butyl D-40 A¹⁾ CN H O-2-ethylhexyl D-41 A¹⁾ H CN O-2-ethylhexyl D-42 A¹⁾ CN H N(CH₃)₂ D-43 A¹⁾ H CN N(CH₃)₂ D-44 A¹⁾ CN H NPh₂ D-45 A¹⁾ H CN NPh₂ D-46 B¹⁾ H H H D-47 B¹⁾ H H OCH₃ D-48 B¹⁾ H H OCH₂CH₃ D-49 B¹⁾ H H O-n-butyl D-50 B¹⁾ H H O-iso-butyl D-51 B¹⁾ H H O-2-butyl D-52 B¹⁾ H H O-2-ethylhexyl D-53 B¹⁾ H H N(CH₃)₂ D-54 B¹⁾ H H NPh₂ D-55 B¹⁾ H CF₃ H D-56 B¹⁾ CF₃ H H D-57 B¹⁾ H CF₃ OCH₃ D-58 B¹⁾ CF₃ H OCH₃ D-59 B¹⁾ H CF₃ OCH₂CH₃ D-60 B¹⁾ CF₃ H OCH₂CH₃ D-61 B¹⁾ H CF₃ O-n-butyl D-62 B¹⁾ CF₃ H O-n-butyl D-63 B¹⁾ H CF₃ O-iso-butyl D-64 B¹⁾ CF₃ H O-iso-butyl D-65 B¹⁾ H CF₃ O-2-butyl D-66 B¹⁾ CF₃ H O-2-butyl D-67 B¹⁾ H CF₃ O-2-ethylhexyl D-68 B¹⁾ CF₃ H O-2-ethylhexyl D-69 B¹⁾ H CF₃ N(CH₃)₂ D-70 B¹⁾ CF₃ H N(CH₃)₂ D-71 B¹⁾ H CF₃ NPh₂ D-72 B¹⁾ CF₃ H NPh₂ D-73 B¹⁾ H CN H D-74 B¹⁾ CN H H D-75 B¹⁾ CN H OCH₃ D-76 B¹⁾ H CN OCH₃ D-77 B¹⁾ CN H OCH₂CH₃ D-78 B¹⁾ H CN OCH₂CH₃ D-79 B¹⁾ CN H O-n-butyl D-80 B¹⁾ H CN O-n-butyl D-81 B¹⁾ CN H O-iso-butyl D-82 B¹⁾ H CN O-iso-butyl D-83 B¹⁾ CN H O-2-butyl D-84 B¹⁾ H CN O-2-butyl D-85 B¹⁾ CN H O-2-ethylhexyl D-86 B¹⁾ H CN O-2-ethylhexyl D-87 B¹⁾ CN H N(CH₃)₂ D-88 B¹⁾ H CN N(CH₃)₂ D-89 B¹⁾ CN H NPh₂ D-99 B¹⁾ H CN NPh₂ D-100 C¹⁾ H H H D-101 C¹⁾ H H OCH₃ D-102 C¹⁾ H H OCH₂CH₃ D-103 C¹⁾ H H O-n-butyl D-104 C¹⁾ H H O-iso-butyl D-105 C¹⁾ H H O-2-butyl D-106 C¹⁾ H H O-2-ethylhexyl D-107 C¹⁾ H H N(CH₃)₂ D-108 C¹⁾ H H NPh₂ D-109 C¹⁾ H CF₃ H D-110 C¹⁾ CF₃ H H D-111 C¹⁾ H CF₃ OCH₃ D-112 C¹⁾ CF₃ H OCH₃ D-113 C¹⁾ H CF₃ OCH₂CH₃ D-114 C¹⁾ CF₃ H OCH₂CH₃ D-115 C¹⁾ H CF₃ O-n-butyl D-116 C¹⁾ CF₃ H O-n-butyl D-117 C¹⁾ H CF₃ O-iso-butyl D-118 C¹⁾ CF₃ H O-iso-butyl D-119 C¹⁾ H CF₃ O-2-butyl D-120 C¹⁾ CF₃ H O-2-butyl D-121 C¹⁾ H CF₃ O-2-ethylhexyl D-122 C¹⁾ CF₃ H O-2-ethylhexyl D-123 C¹⁾ H CF₃ N(CH₃)₂ D-124 C¹⁾ CF₃ H N(CH₃)₂ D-125 C¹⁾ H CF₃ NPh₂ D-126 C¹⁾ CF₃ H NPh₂ D-127 C¹⁾ H CN H D-128 C¹⁾ CN H H D-129 C¹⁾ CN H OCH₃ D-130 C¹⁾ H CN OCH₃ D-131 C¹⁾ CN H OCH₂CH₃ D-132 C¹⁾ H CN OCH₂CH₃ D-133 C¹⁾ CN H O-n-butyl D-134 C¹⁾ H CN O-n-butyl D-135 C¹⁾ CN H O-iso-butyl D-136 C¹⁾ H CN O-iso-butyl D-137 C¹⁾ CN H O-2-butyl D-138 C¹⁾ H CN O-2-butyl D-139 C¹⁾ CN H O-2-ethylhexyl D-140 C¹⁾ H CN O-2-ethylhexyl D-141 C¹⁾ CN H N(CH₃)₂ D-142 C¹⁾ H CN N(CH₃)₂ D-143 C¹⁾ H CN NPh₂ D-144 C¹⁾ CN H NPh₂ D-145 D¹⁾ H H H D-146 D¹⁾ H H OCH₃ D-147 D¹⁾ H H OCH₂CH₃ D-148 D¹⁾ H H O-n-butyl D-149 D¹⁾ H H O-iso-butyl D-150 D¹⁾ H H O-2-butyl D-151 D¹⁾ H H O-2-ethylhexyl D-152 D¹⁾ H H N(CH₃)₂ D-153 D¹⁾ H H NPh₂ D-154 D¹⁾ H CF₃ H D-155 D¹⁾ CF₃ H H D-156 D¹⁾ H CF₃ OCH₃ D-157 D¹⁾ CF₃ H OCH₃ D-158 D¹⁾ H CF₃ OCH₂CH₃ D-159 D¹⁾ CF₃ H OCH₂CH₃ D-160 D¹⁾ H CF₃ O-n-butyl D-161 D¹⁾ CF₃ H O-n-butyl D-162 D¹⁾ H CF₃ O-iso-butyl D-163 D¹⁾ CF₃ H O-iso-butyl D-164 D¹⁾ H CF₃ O-2-butyl D-165 D¹⁾ CF₃ H O-2-butyl D-166 D¹⁾ H CF₃ O-2-ethylhexyl D-167 D¹⁾ CF₃ H O-2-ethylhexyl D-168 D¹⁾ H CF₃ N(CH₃)₂ D-169 D¹⁾ CF₃ H N(CH₃)₂ D-170 D¹⁾ H CF₃ NPh₂ D-171 D¹⁾ CF₃ H NPh₂ D-172 D¹⁾ H CN H D-173 D¹⁾ CN H H D-174 D¹⁾ CN H OCH₃ D-175 D¹⁾ H CN OCH₃ D-176 D¹⁾ CN H OCH₂CH₃ D-177 D¹⁾ H CN OCH₂CH₃ D-178 D¹⁾ CN H O-n-butyl D-179 D¹⁾ H CN O-n-butyl D-180 D¹⁾ CN H O-iso-butyl D-181 D¹⁾ H CN O-iso-butyl D-182 D¹⁾ CN H O-2-butyl D-183 D¹⁾ H CN O-2-butyl D-184 D¹⁾ CN H O-2-ethylhexyl D-185 D¹⁾ H CN O-2-ethylhexyl D-186 D¹⁾ CN H N(CH₃)₂ D-187 D¹⁾ H CN N(CH₃)₂ D-188 D¹⁾ CN H NPh₂ D-189 D¹⁾ H CN NPh₂ D-190 F¹⁾ H H H D-191 F¹⁾ H H OCH₃ D-192 F¹⁾ H H OCH₂CH₃ D-193 F¹⁾ H H O-n-butyl D-194 F¹⁾ H H O-iso-butyl D-195 F¹⁾ H H O-2-butyl D-196 F¹⁾ H H O-2-ethylhexyl D-197 F¹⁾ H H N(CH₃)₂ D-198 F¹⁾ H H NPh₂ D-199 F¹⁾ H CF₃ H D-200 F¹⁾ CF₃ H H D-201 F¹⁾ H CF₃ OCH₃ D-202 F¹⁾ CF₃ H OCH₃ D-203 F¹⁾ H CF₃ OCH₂CH₃ D-204 F¹⁾ CF₃ H OCH₂CH₃ D-205 F¹⁾ H CF₃ O-n-butyl D-206 F¹⁾ CF₃ H O-n-butyl D-207 F¹⁾ H CF₃ O-iso-butyl D-208 F¹⁾ CF₃ H O-iso-butyl D-209 F¹⁾ H CF₃ O-2-butyl D-210 F¹⁾ CF₃ H O-2-butyl D-211 F¹⁾ H CF₃ O-2-ethylhexyl D-212 F¹⁾ CF₃ H O-2-ethylhexyl D-213 F¹⁾ H CF₃ N(CH₃)₂ D-214 F¹⁾ CF₃ H N(CH₃)₂ D-215 F¹⁾ H CF₃ NPh₂ D-216 F¹⁾ CF₃ H NPh₂ D-217 F¹⁾ H CN H D-218 F¹⁾ CN H H D-219 F¹⁾ CN H OCH₃ D-220 F¹⁾ H CN OCH₃ D-221 F¹⁾ CN H OCH₂CH₃ D-222 F¹⁾ H CN OCH₂CH₃ D-223 F¹⁾ CN H O-n-butyl D-224 F¹⁾ H CN O-n-butyl D-225 F¹⁾ CN H O-iso-butyl D-226 F¹⁾ H CN O-iso-butyl D-227 F¹⁾ CN H O-2-butyl D-228 F¹⁾ H CN O-2-butyl D-229 F¹⁾ CN H O-2-ethylhexyl D-230 F¹⁾ H CN O-2-ethylhexyl D-231 F¹⁾ CN H N(CH₃)₂ D-232 F¹⁾ H CN N(CH₃)₂ D-233 F¹⁾ CN H NPh₂ D-234 F¹⁾ H CN NPh₂ D-235 E¹⁾ H H H D-236 E¹⁾ H H OCH₃ D-237 E¹⁾ H H OCH₂CH₃ D-238 E¹⁾ H H O-n-butyl D-239 E¹⁾ H H O-iso-butyl D-240 E¹⁾ H H O-2-butyl D-241 E¹⁾ H H O-2-ethylhexyl D-242 E¹⁾ H H N(CH₃)₂ D-243 E¹⁾ H H NPh₂ D-244 E¹⁾ H CF₃ H D-245 E¹⁾ CF₃ H H D-246 E¹⁾ H CF₃ OCH₃ D-247 E¹⁾ CF₃ H OCH₃ D-248 E¹⁾ H CF₃ OCH₂CH₃ D-249 E¹⁾ CF₃ H OCH₂CH₃ D-250 E¹⁾ H CF₃ O-n-butyl D-251 E¹⁾ CF₃ H O-n-butyl D-252 E¹⁾ H CF₃ O-iso-butyl D-253 E¹⁾ CF₃ H O-iso-butyl D-254 E¹⁾ H CF₃ O-2-butyl D-255 E¹⁾ CF₃ H O-2-butyl D-256 E¹⁾ H CF₃ O-2-ethylhexyl D-257 E¹⁾ CF₃ H O-2-ethylhexyl D-258 E¹⁾ H CF₃ N(CH₃)₂ D-259 E¹⁾ CF₃ H N(CH₃)₂ D-260 E¹⁾ H CF₃ NPh₂ D-261 E¹⁾ CF₃ H NPh₂ D-262 E¹⁾ H CN H D-263 E¹⁾ CN H H D-264 E¹⁾ CN H OCH₃ D-265 E¹⁾ H CN OCH₃ D-266 E¹⁾ CN H OCH₂CH₃ D-267 E¹⁾ H CN OCH₂CH₃ D-268 E¹⁾ CN H O-n-butyl D-269 E¹⁾ H CN O-n-butyl D-270 E¹⁾ CN H O-iso-butyl D-271 E¹⁾ H CN O-iso-butyl D-272 E¹⁾ CN H O-2-butyl D-273 E¹⁾ H CN O-2-butyl D-274 E¹⁾ CN H O-2-ethylhexyl D-275 E¹⁾ H CN O-2-ethylhexyl D-276 E¹⁾ CN H N(CH₃)₂ D-277 E¹⁾ H CN N(CH₃)₂ D-278 E¹⁾ CN H NPh₂ D-279 E¹⁾ H CN NPh₂ B-235 A¹⁾ CH₃ H H B-236 A¹⁾ H CH₃ H B-237 E¹⁾ CH₃ H H B-238 E¹⁾ H CH₃ H B-239 E¹⁾ H H OCH₃ B-240 A¹⁾ H H 2-propoxy B-241 E¹⁾ H H 2-propoxy B-242 D¹⁾ H H 2-propoxy B-243 F¹⁾ CF₃ H H B-244 F¹⁾ H CF₃ H B-245 F¹⁾ H H H B-246 F¹⁾ H H OCH₃


2. An organic electronic device comprising an emitting layer wherein the emitting layer comprises a compound according to claim
 1. 3. The device of claim 1, further comprising a hole transport layer selected from polyvinyl-carbazol, N,N′-diphenyl-N,N′-bis(3-methylphenyl)-[1,1′-biphenyl]-4,4′-diamine (TPD), 1,1-bis[(di-4-tolylamino)phenyl]cyclohexane (TAPC), N,N′-bis(4-methylphenyl)-N,N′-bis(4-ethylphenyl)-[1,1′-(3,3′-dimethyl)biphenyl]4,4′-diamine (ETPD), tetrakis-(3-methylphenyl)-N,N,N′,N′-2,5-phenylenediamine (PDA), a-phenyl-4-N,N-diphenylaminostyrene (TPS), p-(diethylamino)benzaldehydediphenylhydrazone (DEH), triphenylamine (TPA), bis[4-(N,N-diethylamino)-2-methylphenyl](4-methylphenyl)methane (MPMP), 1-phenyl-3-[p-(diethylamino)styryl]-5-[p-(diethylamino)phenyl]pyrazoline (PPR or DEASP), 1,2-trans-bis(9H-carbazol-9-yl)cyclobutane (DCZB), N,N,N′,N′-tetrakis(4-methylphenyl)-(1,1′-biphenyl)-4,4′-diamine (TTB), N,N′-di-α-naphthyl-N,N′-diphenyl-4,4′-diphenyldiamine (α-NPD), porphyrinic compounds, and combinations thereof.
 4. An organic light emitting diode, oxygen sensitive indicator, phosphorescent indicator or catalyst comprises a compound according to claim
 1. 5. The compound of claim 1, having a structure shown below:


6. A compound of formula (Va), (Vb), (VIIa), or (VIIb) shown below:

wherein M² is Rh, Re or Ir, M⁴ is Pd, or Pt, R² and R³ are independently of each other H, C₁-C₈alkyl, C₁-C₈perfluoroalkyl or CN, R⁶ is H, —NR²⁵R²⁶, or C₁-C₁₈alkoxy, wherein R²⁵ and R²⁶ are independently of each other C₁-C₁₈alkyl, or C₆-C₁₀aryl, which may be substituted by one, or more groups C₁-C₁₈alkoxy, or C₁-C₁₈alkyl, L is a bidentate ligand selected from

or L is a bidentate ligand L′ selected from

wherein R¹¹ is hydrogen, C₁-C₈alkyl, C₆-C₁₈aryl, C₂-C₁₀heteroaryl, or C₁-C₈perfluoroalkyl, R¹² is hydrogen, C₆-C₁₈aryl, or C₁-C₈alkyl, and R¹³ is hydrogen, C₁-C₈alkyl, C₆-C₁₈aryl, C₂-C₁₀heteroaryl, C₁-C₈perfluoroalkyl, or C₁-C₈alkoxy, and R¹⁸ is C₆-C₁₀aryl, R¹⁹ is C₁-C₈alkyl, or C₁-C₈perfluoroalkyl, and R²¹ is hydrogen, C₁-C₈alkyl, or C₁-C₈alkoxy, which may be partially or fully fluorinated. 